This Week in Pharmacy

TWIRx NEWS 1. Medicare Part D Paid Nearly $588 Million for Ineligible OTC Drugs   A federal audit found that Medicare Part D sponsors made approximately $587.7 million in ineligible payments from 2021 through 2023 for medications that had effectively transitioned from prescription to over-the-counter status.   The HHS Office of Inspector General cited outdated FDA information and the lack of a clear CMS rejection timeline as major contributors.   Why it matters: This exposes a serious coordination problem across FDA data, manufacturers, CMS, health plans and pharmacy claims systems.   Pharmacists may see the rejection or payment issue at the counter, but the failure often begins far upstream.   Read the Fierce Healthcare report Read the HHS-OIG audit 2. FDA Responds to Estradiol Patch Supply Pressure   The FDA is working with six manufacturers to improve access to estradiol transdermal patches amid increased demand.   While FDA has not declared a national shortage, availability varies by product, strength and geographic area. Manufacturers are increasing production through larger batches, added shifts and expanded capacity.   Why it matters: Pharmacists are again serving as the front line of a supply-chain challenge—helping patients locate medication, coordinating with prescribers and identifying alternatives.   Read the Reuters report Read the FDA update 3. New RSV and COVID-19 Guidance Released   The American Academy of Pediatrics and American College of Obstetricians and Gynecologists have issued updated recommendations for RSV and COVID-19 protection during the 2026–2027 respiratory season.   Why it matters: Pharmacists may face conflicting recommendations, patient confusion and questions about eligibility.   Clear counseling and coordination with pediatric and obstetric providers will be critical.   Read the Pharmacy Times report SPECIAL ANNOUNCEMENT FROM OUTCOMES   A special update from Megan Urban and Outcomes.   Outcomes is highlighting new enhancements to its Rx30 pharmacy management platform, including a refreshed user experience, automated data-entry capabilities and support from a dedicated Client Success Team.   The program will explore how these updates can streamline pharmacy workflows, save time and support greater focus on patient care.   Presented by: Dalia Rios and Kaley Lester September 9, 2026 — 1:30 p.m. ET   Register here FEATURED CONVERSATION Building a Bridge to GLP-1 Access   Our featured guest is HaVy Ngo-Hamilton, PharmD, RPh, Senior Pharmacy Director at Buzz Health.   HaVy works at the intersection of pharmacy, healthcare technology, medication affordability and prescription access.   Buzz Health operates platforms including BuzzRx, RxCompare and RxAffect, with a focus on helping connect patients, pharmacies, prescribers and prescription pricing information.   That makes today’s discussion particularly timely. THE MEDICARE GLP-1 BRIDGE   CMS launched the Medicare GLP-1 Bridge on July 1, 2026, to provide eligible Medicare Part D beneficiaries access to selected GLP-1 medications for weight management.   The demonstration runs through December 31, 2027.   Eligible beneficiaries pay $50 for a monthly supply, while the program operates outside the traditional Part D payment flow through centralized prior authorization, claims adjudication and pharmacy payment.   Eligible therapies currently include:   Foundayo® Wegovy® Zepbound®   The bigger issue is not simply GLP-1 coverage.   It is how healthcare connects eligibility, affordability, prior authorization, pharmacy workflow and patient access.   The central question for today’s discussion:   Can we create a medication-access system where patients know whether they can obtain and afford their therapy before they reach the pharmacy counter? CLOSING THOUGHT   The Medicare GLP-1 Bridge is more than another federal drug program.   It is a real-world test of how healthcare can better connect coverage, affordability, prior authorization and pharmacy fulfillment around high-demand therapies.   Pharmacists remain at the center of that process.   The opportunity is to use technology to move more complexity upstream—allowing pharmacists to spend less time troubleshooting prescriptions and more time caring for patients.   Our thanks to HaVy Ngo-Hamilton, PharmD, RPh, Senior Pharmacy Director at Buzz Health, for joining us on This Week in Pharmacy.   Learn more about the CMS Medicare GLP-1 Bridge   Learn more about Buzz Health   TWIRx — This Week in Pharmacy Pharmacy Podcast Network   Amplifying the Voice of Pharmacy.   Y8mIl2V5tNxFiC3PBxmn

Today’s episode of This Week in Pharmacy — #TWIRx is sponsored by Value Drug Company and explores two major forces reshaping pharmacy: the evolution of the community pharmacy business model and the expanding role of artificial intelligence in medication optimization and value-based care.   PART ONE: The Impact of the Cash-based Community Pharmacy   Special Guest: Rick Seipp, PharmD President, Value Drug Company Community pharmacy is entering a new era.   In Part One, Todd Eury sits down with Rick Seipp, PharmD, President of Value Drug Company, to discuss the continued evolution and expansion of independent community pharmacy and the many different business models emerging across the profession.   Independent pharmacy owners are increasingly evaluating new ways to build sustainable businesses while creating greater professional freedom for pharmacists. One of the most interesting developments is the growth of cash-based and cost-plus pharmacy models that reduce or eliminate dependence on traditional insurance reimbursement and PBM-controlled prescription economics.   These models can give pharmacy owners greater control over pricing, patient relationships, clinical services and the overall direction of their businesses — while allowing pharmacists to practice with significantly less interference from insurance companies and pharmacy benefit managers.   Two pharmacies in the Pittsburgh region are demonstrating how powerful this model can become: Blueberry Pharmacy — Kyle McCormick, PharmD has built Blueberry Pharmacy around a transparent, cash-based model designed to simplify prescription pricing and create a more direct relationship between the pharmacist and patient. Forward Rx Pharmacy — Brandon Antinopoulos, PharmD is another emerging example of how pharmacists can create innovative pharmacy businesses built around transparency, accessibility and freedom from many of the traditional constraints of third-party reimbursement.   Todd and Rick discuss what these models mean for the broader independent pharmacy marketplace and why community pharmacy may be moving toward a much more diversified future.   Sponsored by Value Drug Company, a pharmacist-led wholesale distribution partner committed to supporting the continued growth and independence of community pharmacy. https://lnkd.in/ehf76qUs PART TWO: AI-Powered Medication Optimization   Special Guests: Yoona Kim, PharmD, PhD Co-Founder & CEO, Arine Jenny Behan, PharmD Lead Clinical Pharmacist, Arine In Part Two, #TWIRx shifts from pharmacy business innovation to one of the most important developments occurring in clinical pharmacy: the use of artificial intelligence to optimize medication therapy at scale. Arine is an AI-powered medication optimization platform designed to improve patient outcomes and reduce healthcare costs by helping ensure patients receive the most effective and appropriate medications. Listen to This Week in Pharmacy — TWIRx on the Pharmacy Podcast Network across Apple Podcasts, Spotify, Amazon Music, iHeartRadio, YouTube and all major podcast platforms.   Pharmacy Podcast Network — Amplifying the Voice of Pharmacy. Y8mIl2V5tNxFiC3PBxmn  

Pharmacists and Advocacy for Patients in Pain  Friday, August 21, 2026 What happens when patients living with chronic pain, their advocates, and the pharmacists responsible for dispensing opioid medications view the same healthcare system from very different perspectives? This special episode of This Week in Pharmacy brings together the Doctor Patient Forum’s founders, Claudia A. Merandi and Bev C. Schechtman, with pharmacist and nationally recognized pharmacy advocate Dr. Shane Jerominski, PharmD—better known as “The Accidental Pharmacist.” The discussion follows a wave of social-media debate surrounding Claudia’s use of the term “Harmacists,” which prompted responses from hundreds of pharmacists who felt the label misrepresented their professional responsibilities and the legal restrictions under which they practice. Rather than allow that controversy to deepen the divide, TWIRx created an opportunity for direct, respectful conversation. The purpose of this episode is to help pain-patient advocates better understand the limits pharmacists face when dispensing opioids—and to identify opportunities for pharmacists and patient organizations to advocate together for safe, compassionate and uninterrupted pain care. Five Legal and Supply-Chain Realities Affecting Opioid Dispensing Pharmacists have a federal “corresponding responsibility.” Under 21 CFR §1306.04, a controlled-substance prescription must be issued for a legitimate medical purpose. Pharmacists share legal responsibility with prescribers for determining whether a prescription is valid. Knowingly filling an illegitimate prescription may expose the pharmacist to federal penalties and professional discipline. Review the federal regulation. Schedule II prescriptions must satisfy strict requirements. Federal law generally requires a valid written or compliant electronic prescription before a Schedule II opioid may be dispensed. Emergency oral prescriptions are permitted only under limited conditions and require prescriber follow-up documentation. Schedule II opioid prescriptions cannot be refilled. Under federal law, every additional dispensing generally requires a new prescription. Partial fills are allowed only under specific circumstances, documentation requirements and time limits. Pharmacists cannot simply extend or refill opioid therapy when a patient or prescriber requests it. State laws add another layer of requirements. Depending on the state, pharmacists may have to verify prescriber authority, review prescription-monitoring information, validate electronic or security-form requirements, confirm identification, document partial fills, or comply with state-specific dispensing limitations. For example, California requires controlled-substance prescriptions to meet defined security and validity standards. California Board of Pharmacy guidance. Wholesaler monitoring can restrict a pharmacy’s opioid supply. DEA-registered distributors must identify and report suspicious controlled-substance orders under 21 CFR §1301.74. National wholesalers therefore operate monitoring programs that may delay, limit or suspend shipments based on ordering patterns, geography, drug mix and internal thresholds. These controls are imposed upstream and can leave a pharmacy unable to obtain medication—even when the pharmacist believes a prescription is clinically and legally appropriate. Review the federal distributor requirements. These examples are not exhaustive. Pharmacists must navigate overlapping federal law, DEA requirements, state pharmacy and controlled-substance laws, prescription-monitoring systems, employer policies, payer rules, wholesaler restrictions and professional standards. Requirements also vary by state and by the circumstances surrounding an individual prescription. The Central Question How can pain-patient advocates and pharmacists move beyond blame and work together to address the policies, supply restrictions, staffing conditions and regulatory pressures that can interfere with appropriate care? This conversation explores: Why patients may interpret a refusal or delay as judgment, discrimination or abandonment Why pharmacists cannot treat a valid prescriber signature as automatic authorization to dispense How PDMP and risk-scoring information can influence clinical decisions The effect of corporate policies and wholesaler ordering controls The difference between professional judgment and stigma The communication failures that damage trust between patients, prescribers and pharmacists How advocacy organizations and pharmacists can pursue policy reform together Why patients deserve clear explanations, respectful treatment and continuity-of-care planning How pharmacists can remain vigilant without losing empathy for people living with pain About the Doctor Patient Forum The Doctor Patient Forum, founded by Claudia A. Merandi and Bev C. Schechtman, combines healthcare education, research, digital influence and patient advocacy to address the consequences of opioid-reduction policies and barriers to individualized pain care. Claudia A. Merandi is an advocate and educator whose work contributed to a Rhode Island law protecting access to pain management. Since 2016, she has built a growing national audience while documenting systemic harms experienced by patients and healthcare professionals. Bev C. Schechtman is a researcher, advocate and educator who examines opioid-reduction policies, prescription drug monitoring programs and surveillance technologies such as NarxCare. Her work helps patients understand and navigate an increasingly complex healthcare system. Learn more: The Doctor Patient Forum About Dr. Shane Jerominski, PharmD Dr. Shane Jerominski is a pharmacist, Navy veteran and nationally recognized pharmacy advocate known as “The Accidental Pharmacist.” In 2025, his professional peers selected him as one of the “50 Most Influential People in Pharmacy.” Through his influential social-media platform, Shane combines humor, candid commentary and frontline experience to advocate for safer working conditions, professional unity and meaningful reform throughout pharmacy practice. He is also a co-founder of The Pharmacy Guild and has become a prominent voice for pharmacists and pharmacy technicians nationwide. A Call for Collaborative Advocacy Patients should not be stigmatized because they require pain treatment. Pharmacists should not be vilified for complying with laws and professional obligations that can place their licenses and livelihoods at risk. Progress requires both communities to recognize that many barriers originate beyond the pharmacy counter. Patients, pharmacists, prescribers and advocacy organizations share an interest in policies that protect medication safety without denying appropriate, individualized care. The goal is not to determine which group has suffered more. The goal is to replace mistrust with understanding—and turn that understanding into stronger, unified advocacy. This episode is intended for education and discussion. It does not provide legal or medical advice, and regulatory requirements may differ by jurisdiction and circumstance.   Y8mIl2V5tNxFiC3PBxmn

Independent pharmacies need partners they can trust—and patients need a prescription-drug system that puts access ahead of profits. In this episode of This Week in Pharmacy, Todd Eury welcomes Rick Seipp, PharmD, President of Value Drug Company, to discuss the importance of choosing a dependable wholesale distribution partner. Following Smith Drug Company’s announced operational transition, Value Drug Company is prepared to help affected independent pharmacy owners evaluate their purchasing, distribution and operational needs while developing an orderly transition that protects continuity of service. For more than 90 years, pharmacist-led Value Drug Company has supported community pharmacies through transparent pricing, dependable distribution, collective purchasing power and programs designed to improve efficiency, growth and profitability. Rick explains how the company will provide transition assistance and regional gatherings where pharmacy owners can speak directly with Value Drug Company leadership. The episode also features a follow-up conversation with patient advocate Bil Schmidtknecht about the continuing fight for Cole’s Act. Named in memory of Bil’s son, Cole, the proposed reforms seek to protect patients from unexpected formulary and coverage changes that can suddenly make essential medications unaffordable. “Patients can’t afford more delays, and lives should never be collateral damage in a profit-driven system,” Bil says. The discussion examines PBM accountability, medication affordability and why families must receive meaningful notice before coverage changes place lifesaving treatments beyond their reach. TWIRx News: Week Ending August 14, 2026 Employers Are Moving Away from the “Big Three” PBMs A new employer survey points to growing disruption in the PBM marketplace. Forty-six percent of surveyed employers reported using a PBM outside CVS Caremark, Express Scripts and Optum Rx—up from 37% the previous year. Employers are increasingly seeking transparent pricing, access to claims data and greater control over prescription-drug spending. Read the Axios report FDA Delays Major iPLEDGE Changes Until November The FDA has postponed implementation of updated iPLEDGE REMS requirements from August 8 to November 15, 2026, to allow additional system testing. The forthcoming changes are intended to reduce burdens on patients, pharmacists and prescribers while maintaining safeguards surrounding isotretinoin. Read the FDA iPLEDGE update   Episode Resources Value Drug Company transition-support announcement Value Drug Company transition assistance: 1-866-226-1772 Patient Protector Modern Medical Mafia: PBM Reform Pharmacy Podcast Network About the Guests Rick Seipp, PharmD President, Value Drug Company Bil Schmidtknecht Patient advocate and father of Cole Schmidtknecht The Value of a Trusted Wholesaler & Cole’s Act Update | TWIRx

In the first episode of this three-part CurifyLabs Podcast Series, we provide a broad overview of the CurifyLabs platform and its role in modernizing personalized medicine and pharmaceutical compounding. The discussion explores how the platform combines digital workflows, automated production technology, and standardized processes to help pharmacies and healthcare organizations improve efficiency, consistency, quality, and scalability.   Listeners will learn how CurifyLabs supports the preparation of customized medications while helping pharmacy teams reduce manual complexity, strengthen documentation, and expand access to patient-specific therapies. This opening episode establishes the foundation for the series and examines how technology can help transform the future of pharmaceutical compounding.

This Week in Pharmacy — August 7, 2026 The Hidden Cost of Managing Pain Without a Pain Pharmacist What happens when patients living with chronic pain do not have a pain pharmacist on their healthcare team? In this episode of This Week in Pharmacy, we explore the hidden clinical, emotional, and financial costs of managing pain without a pharmacist trained in pain management. These pharmacists do far more than review medications—they serve as accessible patient advocates, medication experts, care coordinators, and trusted partners for people navigating the complexities of chronic pain. Segment One: Pharmacists Are the Secret Weapon in Pain Management Special guest host Dr. Sing Ping Chow, PharmD, BCPMP, is joined by Dr. Matthew Hermenau, PharmD, BCPMP, CPh, NBC-HWC, CPT, for an important discussion about pharmacist-led pain management. Together, they examine how pain pharmacists can: Identify medication-related risks and opportunities to improve therapy Help patients balance pain relief, function, safety, and quality of life Collaborate with prescribers and other members of the healthcare team Support individualized, evidence-informed treatment plans Educate and empower patients living with chronic pain Advocate for patients whose concerns may otherwise go unheard Address the whole person—not simply a diagnosis or pain score   The conversation reinforces a powerful message: pharmacists are one of healthcare’s most underused resources in chronic pain care. When a pain pharmacist is part of the team, patients gain a knowledgeable advocate who understands medications, listens to their lived experiences, and helps them pursue safer and more effective care.   Remembering Dr. Jeffrey Fudin   This episode includes a special tribute to the late Dr. Jeffrey Fudin, PharmD, widely regarded as pharmacy’s godfather of pharmacist-led pain management.   Dr. Fudin was a pioneering clinician, educator, author, mentor, and tireless advocate for the meaningful inclusion of pharmacists in pain care. His work challenged conventional thinking, elevated the role of the pharmacist, and helped build a path for future generations of pain-management specialists.   His influence continues through the pharmacists he mentored, the patients he championed, and the profession he inspired. We honor Dr. Fudin’s legacy and his unwavering belief that people living with pain deserve informed, compassionate, and individualized care.   Segment Two: The Nation’s Best Hospital Systems In the second segment, we welcome Chelsey Wen, Senior Health Data Analyst with U.S. News & World Report, to discuss the newly released 2026–2027 Best Hospitals rankings. Chelsey explains how U.S. News evaluates hospital performance and how patients and families can use the findings when making healthcare decisions. The latest assessment evaluated nearly 4,500 hospitals across 14 adult specialties and 23 procedures and conditions. It places increased emphasis on patient outcomes and introduces regional specialty rankings designed to help patients locate complex care closer to home. Explore the 2026–2027 Best Hospitals announcement.   link: https://health.usnews.com/best-hospitals Topics include: What it means for a hospital to be nationally ranked or rated “High Performing” The clinical data and patient outcomes considered in the evaluation Changes to the 2026–2027 rankings and methodology The importance of regional rankings and access to specialized care How patients should interpret hospital rankings when choosing where to receive care Sponsored By Today’s episode of This Week in Pharmacy is brought to you by First Databank and Outcomes, pharmacy-technology organizations supporting safer, smarter, and more connected healthcare.

The Independent Pharmacy Cooperative is partnering with Fullscript to help independent pharmacies expand their wellness offerings without adding inventory, storage costs, or fulfillment responsibilities.   Through the partnership, IPC members receive free access to Fullscript’s digital platform, featuring more than 375 trusted supplement brands. Pharmacies can recommend personalized wellness protocols, earn approximately 35% margins on online sales, and benefit from direct-to-patient shipping, automated refill reminders, and optional auto-ship services.   Fullscript manages product inventory, payment processing, and delivery, giving independent pharmacies a practical way to generate recurring revenue while supporting patient adherence and long-term wellness goals.   Guests:   Kelli - IPC Christopher - FullScript Shannon - IPC Andrea - Pharmacy Owner Emlah Tubuo - Pharmacy Owner

Independent pharmacies are facing growing reimbursement uncertainty, especially when dispensing high-cost brand medications such as GLP-1 therapies. In this exclusive Pharmacy Podcast Network special feature, we examine how GoodRx Community Link provides independent pharmacies with predictable pricing and favorable economics across both brand and generic medications, ultimately helping pharmacies remain solvent while providing consumers affordable prescription prices.   Todd Eury is joined by David Graziano, Head of Retail Network at GoodRx, and Tom DePietro, independent pharmacy owner at DePietro’s Pharmacy, for a practical discussion about the pressures affecting independent pharmacy and the need for reimbursement models that support  pharmacy viability.   The conversation explores how Community Link supports brand medications through manufacturer-funded savings that flow back to the pharmacy through GoodRx, while the manufacturer covers the administrative fee. For generic medications, the program uses a NADAC-based cost-plus model intended to provide clearer visibility into reimbursement.   Listeners will also hear how independent pharmacies are impacted by rising deductibles, prior authorizations, narrow formularies, cash-pay growth, and increased competition. David and Tom discuss the importance of transparent pricing, digital engagement, streamlined fulfillment, personalized patient care, and sustainable economics for local pharmacies.   Key discussion points include: The financial risk of dispensing high-cost brand medications like GLP-1s Predictable reimbursement for brands and generics The role of manufacturer-funded savings for brand medications NADAC-based cost-plus pricing for generics Pharmacy access to GLP-1 cash-pay programs Competing through service, technology, and patient relationships Protecting local healthcare access through independent pharmacy   Explore how GoodRx Community Link can bring greater transparency and predictability to brand and generic dispensing, helping independent pharmacies serve patients sustainably and with confidence.   Featured Guests: David Graziano — Head of Retail Network, GoodRx Tom DePietro — Independent Pharmacy Owner, DePietro’s Pharmacy   Host: Todd Eury — Founder, Pharmacy Podcast Network   Visit goodrx.com/CommunityLink to learn more GoodRx is NOT insurance.

Specialty pharmacy is becoming one of the most important access points in modern healthcare, particularly for patients managing complex, chronic, rare, and high-cost conditions. As therapies advance and patient needs become more sophisticated, health systems are rethinking how specialty pharmacy can improve medication access, continuity of care, clinical outcomes, affordability, and the overall patient experience.   In this special episode of This Week in Pharmacy, the Pharmacy Podcast Network introduces Specialty Care Close to Home, a new series examining how hospitals and health systems are designing, building, supporting, and scaling specialty pharmacy services across health-system and community-based care models.   Featured Guests   Dr. Laura Mark, PharmD Vice President of Pharmacy, Allegheny Health Network   Allison Arant Senior Vice President, Clearway Health   Chris Corsi Chief Executive Officer, CassianRx   Together, the guests discuss why health-system specialty pharmacy expansion matters, what successful programs require, and where the greatest strategic and operational challenges exist. The conversation explores how strong partnerships, integrated clinical workflows, patient-centered technology, and coordinated care teams can reduce fragmentation and improve specialty medication access.   Discussion Highlights The growing strategic role of health-system specialty pharmacy Keeping patients connected to trusted local care teams Improving access, adherence, affordability, and therapy management Building scalable specialty pharmacy infrastructure Integrating clinical, operational, and technology capabilities Overcoming payer, workflow, workforce, and reimbursement challenges Creating collaborative models that support long-term sustainability   Future episodes of Specialty Care Close to Home will explore accreditation, payer access, manufacturer relationships, clinical workflow, patient engagement, technology infrastructure, data reporting, community access, workforce development, and financial sustainability.   The series will also feature pharmacy directors, vice presidents, executives, operators, and innovators from health systems across the country who are leading the next generation of specialty care delivery.   Host: Todd Eury, Founder of the Pharmacy Podcast Network   Coming Soon: Specialty Care Close to Home—a national conversation about bringing advanced specialty pharmacy services closer to where patients live, work, and receive care.

AI in Pharmacy Standards and Drug Supply Chain Upgrades This Week in Pharmacy — July 17, 2026   Artificial intelligence and supply chain modernization are reshaping pharmacy practice, patient access, and healthcare operations.   In this episode of This Week in Pharmacy, host Todd Eury speaks with leaders from URAC and Cencora about responsible AI adoption and the growing gap between drug availability and real-world access.   Guests   Shawn Griffin, MD President and CEO, URAC   Brent Wilhelm Senior Vice President, Global Supply Chain Center of Excellence, Cencora   Tim Weber Pharmacy Operations and Regulatory Executive   AI is already supporting clinical documentation, patient communication, risk prediction, and workflow automation. URAC President and CEO Shawn Griffin, MD, explains why healthcare organizations need clear governance, defined accountability, human oversight, and continuous monitoring before deploying AI at scale.   The discussion addresses transparency, performance evaluation, bias, data integrity, cybersecurity, and the role accreditation standards may play in promoting safe and responsible AI adoption.   Governance and accountability for AI outputs Human review of AI-supported decisions Monitoring safety, accuracy, and bias The role of accreditation in AI oversight Balancing innovation with patient protection   Drug Availability Versus Patient Access   Brent Wilhelm of Cencora discusses why a medication may exist somewhere in the supply chain but still remain difficult for providers to obtain.   Dosage limitations, delivery timing, ordering complexity, reimbursement barriers, cold-chain requirements, and site-of-care restrictions can all delay patient access.   Wilhelm explains why the industry must look beyond inventory levels and focus on whether providers can obtain the correct therapy, at the right location, when the patient needs it.   Inventory visibility versus actual access Differences across pharmacies and sites of care Specialty and temperature-sensitive therapies Provider demand forecasting Reducing delays, shortages, and waste   Tim Weber adds the pharmacy operations and regulatory viewpoint, discussing inventory planning, compliance, product tracing, reimbursement, and patient fulfillment.   The conversation highlights the need for better coordination among manufacturers, distributors, pharmacies, health systems, payers, and regulators.

Integrative Care Impact and the Expanding Role of the Pharmacist | TWIRx Today’s episode of This Week in Pharmacy explores two major opportunities shaping the future of the profession: the growth of holistic and integrative pharmacy services inside community pharmacies, and the expanding demand for pharmacists across the business, insurance, and PBM sectors. In our first segment, Todd Eury welcomes special guests Robert Kress, RPh, and Dr. Bianca Bradshaw, PharmD, owner of Elmore Pharmacy in Red Bluff, California. Together, they discuss the tremendous opportunity for independent pharmacies to build holistic and integrative health departments that respond to growing consumer demand for natural products, supplements, wellness solutions, and personalized care. Dr. Bianca Bradshaw, PharmD https://www.linkedin.com/in/bianca-bradshaw-141092205/ Patients are increasingly seeking more natural approaches to health, but they still need trusted clinical guidance. Community pharmacists are uniquely positioned to help patients evaluate products, avoid harmful interactions, understand evidence, and develop safer, more effective wellness plans. This conversation explores how pharmacies can create new service lines, improve patient relationships, and establish sustainable revenue opportunities through integrative care. In our second segment, Dr. Bonnie Hui-Callahan, PharmD, returns to the show to discuss career opportunities for pharmacists within Judi Health and Capital Rx, as well as the broader business and insurance side of pharmacy. Dr. Bonnie Hui-Callahan, PharmD https://www.linkedin.com/in/bonnie-hui-callahan/ As PBMs continue to evolve, new-generation models are creating demand for pharmacists who understand clinical care, benefits, formulary strategy, patient access, data, and healthcare economics. Bonnie shares why pharmacists will remain essential as PBMs transform and why the profession should look beyond traditional dispensing and clinical practice roles when considering future career paths. Today’s episode is sponsored by Independent Pharmacy Cooperative and SuiteRx. Listen to This Week in Pharmacy on the Pharmacy Podcast Network.

Today e celebrate 250 Years of Freedom during this 4th of July special with Scotty Sykes with Sykes & Company Pharmacy Accounting Experts. Next, a special interview with Virginia Halsey SVP of Strategy and Product Management and Brad Engels Product Manager at First Databank (FDB).  Today's TWIRx is sponsored by Sykes & Company  250 Years of Freedom - 4th of July Special | TWIRx 

THIS WEEK IN PHARMACY PBM Truth, Cash-Based Pharmacy, and Psychedelics in Medicine Presented by SuiteRx Pharmacy Software Technologies Learn more at SuiteRx.com Episode Overview On this episode of This Week in Pharmacy, Todd Eury brings together two timely conversations focused on pharmacy transformation, advocacy, clinical education, and the future role of pharmacists in healthcare. First, Todd welcomes Brad Hart, owner of Forest Park Pharmacy, a cash-based independent pharmacy model challenging the traditional reimbursement structure many pharmacies operate under. Brad has become a powerful advocate for pharmacy transparency, using TikTok and social media to expose current PBM practices, share data, and speak directly to patients, pharmacy owners, and policymakers about the realities facing independent pharmacies. Brad’s message is clear: patients deserve transparency, pharmacy owners deserve fair treatment, and the profession needs more voices willing to educate the public with facts and truth. In the second half of the episode, Todd is joined by Dr. Colby Burns and Dr. Andy Krut from the Psychedelic Pharmacists Association. This discussion helps set the groundwork for understanding psychedelics in medicine, the evolving role of pharmacists in psychedelic education, and the clinical potential of psychotropic therapies historically limited by regulation, stigma, and lack of provider education. As interest in psychedelic-assisted care grows, pharmacists must be part of the conversation. Dr. Burns and Dr. Krut explain why pharmacist education, medication safety, and clinical understanding are essential as healthcare explores emerging approaches to mental health, trauma, pain, and complex patient care. Featured Guests Brad Hart Owner, Forest Park Pharmacy Dr. Colby Burns Psychedelic Pharmacists Association Dr. Andy Krut Psychedelic Pharmacists Association Sponsored By This episode of This Week in Pharmacy is brought to you by SuiteRx Pharmacy Software Technologies. SuiteRx provides pharmacy software solutions designed to support independent pharmacies, improve workflow, enhance patient care, and help pharmacy teams operate more efficiently in today’s demanding healthcare environment. Learn more at SuiteRx.com.

On this episode of This Week in Pharmacy, we bring together three powerful voices shaping the future of pharmacy, independent practice, functional medicine, and healthcare transformation.   First, we welcome Kris Rhea, MBA, Contributing Editor with Dispense Times, a digital publication dedicated to supporting independent community pharmacy owners across the United States. Kris brings a business-focused perspective on pharmacy operations, growth strategy, workflow efficiency, data-driven decision-making, and market positioning. His work with Dispense Times helps independent pharmacists navigate today’s rapidly changing healthcare landscape, including PBM pressures, evolving patient expectations, regulatory challenges, and the need for sustainable business models that keep local pharmacies strong.   We also speak with James Maskell, founder of Evolution of Medicine, an organization built to inspire, equip, and unite functional and integrative medicine practitioners. Evolution of Medicine provides education, practice-building resources, and community for clinicians who are working to build thriving practices rooted in whole-person care. James brings a national perspective on the movement toward functional medicine, community-based care, prevention, and new models that empower practitioners to better serve patients beyond the limitations of conventional healthcare.   Our third guest is Marina Buksov, PharmD, a pharmacist, herbalist, educator, podcast host, and holistic health consultant. After earning her PharmD from St. John’s University and graduating Summa Cum Laude in 2013, Marina entered pharmacy eager to serve patients, but quickly recognized that traditional allopathic pharmacy did not fully align with her deeper calling to help people thrive through prevention, root-cause care, plant medicine, and sustainable wellness strategies. Her experience behind the pharmacy counter and as a patient herself inspired her to pursue health coaching, nutrition, functional medicine, and clinical herbalism. Today, Marina helps pharmacists and healthcare professionals explore natural-minded career paths and build meaningful work that bridges pharmacology, herbal therapeutics, and holistic care.   Together, this episode explores where pharmacy is headed: independent pharmacy survival, business model innovation, functional medicine, patient-centered care, pharmacist reinvention, and the growing demand for healthcare professionals who can connect science, prevention, and real-world practice.   Listen to This Week in Pharmacy on the Pharmacy Podcast Network. Pharmacy’s future is being built by those willing to challenge the current model, support independent practice, and expand the role of pharmacists as trusted healthcare providers.

On this episode of This Week in Pharmacy, we examine three major forces shaping healthcare today: the global impact of conflict on health security, the continued evolution of personalized specialty pharmacy care, and the over-the-counter products patients rely on most.   We open the show with Aman Gupta, Managing Partner, Asia-Pacific at SPAG FINN Partners, and contributor author at MedikaLife. Aman joins TWIRx to discuss his latest MedikaLife article, which argues that global conflict is quietly undermining health security by redirecting funding, attention, and infrastructure away from healthcare and toward defense priorities.   As military spending rises, health systems—especially in low- and middle-income countries—face growing pressure from shrinking access, rising costs, workforce shortages, disrupted supply chains, weakened disease surveillance, and reduced emergency preparedness. Conflicts in Ukraine, Gaza, and Sudan demonstrate how attacks on healthcare systems, displacement, malnutrition, and shortages of essential medicines can rapidly turn health access into a survival issue. Aman urges policymakers to treat health as strategic security infrastructure, not as a secondary social expense.   TWIRx also gives a special shout out to the Indian Pharmaceutical Association, recognizing its continued leadership and advocacy for the pharmacy profession.   Next, we welcome Dr. Chris Antypas, PharmD, with Perigon Pharmacy 360, for a discussion on how specialty pharmacy is becoming increasingly personalized. As complex therapies continue to advance, pharmacists are playing a critical role in ensuring medications and treatment plans are customized to optimize patient care. We explore how technology, workflow processes, clinical expertise, and pharmacists who deeply understand specific disease states are essential to successful specialty pharmacy outcomes.   To wrap up the episode, returning guest Shanley Chien Pierce, Senior Editor, Health at U.S. News & World Report, joins us to review the latest OTC medicine and health product evaluations. Top-rated products include Children’s Delsym for coughs, Unisom for sleep, and Pedialyte for electrolytes, along with skincare favorites such as La Roche-Posay for retinol and Aquaphor for lip balm.   For the full list covering more than 128 categories, visit the U.S. News Best OTC Medicine & Health Products rankings.   Sponsored by Perigon Pharmacy 360 Listen & Subscribe Stay connected with This Week in Pharmacy and the Pharmacy Podcast Network for conversations with pharmacy leaders, healthcare innovators, policy experts, and industry voices shaping the future of care.

On this episode of This Week in Pharmacy, we examine two major forces reshaping the profession: the unfinished business of pharmacist provider status and the legal landscape around direct-to-consumer pharmaceutical distribution. In part one, Erik Abel, PharmD, MBA, discusses his May 2026 analysis, “So Pharmacists Want to Be a Provider: Where the Profession Lost Its Way and Perhaps a Path to Get Back.” Abel argues that pharmacy’s provider-status challenge is not a lack of clinical evidence, but a lack of operational infrastructure: credentialing, payer contracting, revenue cycle management, interoperability, and scalable business models. In part two, Darshan Kulkarni, PharmD, Esq., joins the show to discuss direct-to-consumer pharmaceutical distribution, legal risk, regulatory scrutiny, telehealth-linked prescribing, manufacturer strategy, and what pharmacists need to understand as drug distribution moves closer to the patient. This week in pharmacy news, Pittsburgh-area pharmacies continue to face uneven access to Adderall and other ADHD medications, years after the FDA first identified shortages in 2022. Patients are still calling multiple pharmacies, switching medications, rationing doses, or going without treatment as availability varies by dosage, formulation, manufacturer, and wholesaler. Pharmacists are also using medication therapy management to protect older adults from preventable medication-related harm. MTM reviews can identify risky prescriptions and OTC products, including diphenhydramine, duplicate therapies, drug interactions, and long-term proton pump inhibitor use that may need reassessment. In 340B news, CVS Health is facing federal lawsuits from major health systems alleging CVS Specialty and WellPartner improperly retained approximately $250 million in savings that should have gone back to covered entities. The litigation adds pressure to debates over PBM integration, contract pharmacy arrangements, and 340B transparency. On Capitol Hill, lawmakers are pressing the Department of Defense to commit to annual audits of the TRICARE pharmacy contract as concerns continue around PBM conflicts of interest, reimbursement practices, network adequacy, and access for independent and community pharmacies.

This week, This Week in Pharmacy examines several stories shaping the business, clinical, and legal future of pharmacy practice. In TWIRx News from Pharmacy Times from Megan Maroney, PharmD, BCPP, FAAPP, focused on antidepressant use, withdrawal concerns, deprescribing, and shared decision-making. The key takeaway: patients should never stop antidepressants abruptly. Pharmacists can play a vital role in reducing stigma, educating patients, and supporting safe conversations about tapering, side effects, and long-term treatment. In health technology news, FDB research presented at the 2026 AMIA Amplify Informatics Conference found that patient-specific, risk-based medication guidance reduced pharmacy alert volume by 70% in a high-volume community pharmacy setting. The model consolidates alerts into one actionable message tied to the patient’s most relevant risk, helping reduce alert fatigue and improve workflow. Finally, we review a federal court ruling in Eli Lilly’s lawsuit against Houston-based Empower Pharmacy over compounded tirzepatide versions of Mounjaro and Zepbound. The judge dismissed key federal trademark and Texas unfair competition claims, while allowing other state claims to continue. Andy Crawford, with Keysource is back on TWIRx talking about the U.S. Supreme Court taking up Hikma Pharmaceuticals USA Inc. v. Amarin Pharma Inc., a case that could significantly affect generic drug competition. At issue is whether Hikma’s marketing materials and public communications around its generic version of Amarin’s fish oil-based cardiovascular drug improperly promoted a still-patented use. Hikma and the broader generic industry argue the case is about protecting “skinny label” rules, which allow generics to carve out patented indications while still bringing lower-cost medications to market. For pharmacists, the decision could influence generic availability, substitution confidence, pricing pressure, and how manufacturers communicate with providers and pharmacies. Thanks to our sponsors, CassianRx and IPC, for supporting independent pharmacy, innovation, and the future of patient-centered care.

Sponsored by Rx4Route This Week in Pharmacy returns with a timely two-part episode focused on pharmacy operations, medication access, and the growing responsibility of healthcare communicators in the age of AI. In our first segment, we welcome Joseph Dymowski, PharmD, CEO of Centennial Pharmacy Services, and Doniyor Sattarov, Vice President of Operations at Rx4Route, for a conversation about expanding long-term care pharmacy at home. As more patients age in place, pharmacies must rethink delivery, logistics, documentation, and patient communication as essential parts of care. Delivery is no longer just a convenience. It is a critical extension of pharmacy services. Reliable routing, real-time tracking, and proof of delivery help pharmacies improve adherence, reduce operational friction, and build stronger trust with patients, caregivers, and providers. Expanding LTC pharmacy-at-home services, building scalable delivery workflows, improving route efficiency, using delivery technology to support compliance, and why logistics may become a major competitive advantage for pharmacies. This episode is sponsored by Rx4Route, pharmacy delivery software designed to help pharmacies streamline delivery operations, optimize routes, track orders, and improve proof-of-delivery workflows. In our second segment, we speak with **Vincent Grippi, CEO of Grippi Media, about the dangers of AI-generated misinformation and the higher standard required in healthcare communications. As AI becomes more common in content creation, communications professionals must protect accuracy, credibility, and patient trust. In healthcare, misinformation can influence clinical understanding, damage reputations, and create confusion across the industry. That is why content for healthcare professionals must be reviewed, verified, and guided by human judgment. AI misinformation in healthcare, responsible content development, source verification, editorial review, subject-matter expertise, and how communicators can use AI without sacrificing trust. This episode connects two critical forms of trust in pharmacy: operational trust at the patient’s door and informational trust across every communication channel. Featured Guests: Joseph Dymowski, PharmD— CEO, Centennial Pharmacy Services Doniyor Sattarov— Vice President of Operations, Rx4Route Vincent Grippi— CEO, Grippi Media

Congratulations to Logan Eury and his new wife Emily, got married today, May 1, 2026!  This C.O. Bigelow Collab Introduces the 188-Year-Old Pharmacy to a New Generation Abbode is taking over the Carolyn Bessette-Kennedy-approved shop for a month-long pop-up. https://fashionista.com/2026/05/co-bigelow-abbode-pop-up-carolyn-bessette-impact  The article highlights how a pop-up and renewed interest in C.O. Bigelow has been fueled by the cultural resurgence of Carolyn Bessette-Kennedy’s minimalist style, amplified by media and social buzz. This renewed attention has driven significant foot traffic and sales, showing how storytelling, nostalgia, and “quiet luxury” aesthetics can translate into real retail impact.   Q&A: Mayo Clinic leaders share strategies for managing high-cost drugs without breaking the bank | Asembia AXS26 Summit https://www.managedhealthcareexecutive.com/view/q-a-mayo-clinic-leaders-share-strategies-for-managing-high-cost-drugs-without-breaking-the-bank-asembia-axs26-summit Mayo Clinic leaders emphasize that managing high-cost drugs requires clear definitions, structured formulary review processes, and multidisciplinary collaboration to balance cost, access, and clinical value. They highlight the importance of evaluating safety, efficacy, financial impact, and site-of-care decisions together, while noting that non-340B systems face increasing pressure from rising costs and reimbursement constraints. Ultimately, success depends on stronger alignment between health systems, manufacturers, and payers to sustain access without compromising quality of care.  Where Gross-to-net Pressure Actually Lives After Launch Today’s guest post comes from Cindy Baksh, Chief Product Officer at ConnectiveRx. https://www.drugchannels.net/2026/05/where-gross-to-net-pressure-actually.html The article explains that “gross-to-net pressure” isn’t driven by a single factor, but by a combination of rebates, discounts, fees, and policy changes that continue to reshape how drug pricing actually works behind the scenes. As the industry shifts toward a “net pricing” model, traditional rebate-driven strategies are weakening, forcing manufacturers, PBMs, and pharmacies to rethink how value and profits are generated. Today's featured guest is Dr. Ndidiamaka Okpareke PharmD for Congress Dr. Ndidiamaka “Didi” Okpareke, PharmD, is a pharmacist, entrepreneur, and political candidate running for Congress in New Mexico’s 1st Congressional District. A first-generation Nigerian-American, she built her career in healthcare after graduating from the University of New Mexico College of Pharmacy and went on to found and lead a successful compounding pharmacy serving her community.  Motivated by nearly two decades of patient care experience, Okpareke entered the political arena to address challenges such as healthcare access, rising costs, and the shortage of providers in New Mexico. Running as a Republican, she emphasizes strengthening healthcare systems, supporting economic growth, and preserving opportunity for future generations, positioning herself as a community-focused leader bringing frontline healthcare insight into public policy.  This special episode highlights how TJM Labs is redefining pharmacy operations through AI-driven automation, bringing together insights from industry leaders Bhavesh Patel, PharmD—CEO of Carepoint Pharmacy—and Jonathan Adly, PharmD, MBA—CEO of TJM Labs. At the center of the conversation is how modern pharmacies are facing rising prescription volumes, staffing constraints, and increasing operational complexity, and why traditional manual workflows can no longer keep pace. TJM Labs addresses this challenge by deploying AI-powered “digital workers” that automate tasks like prescription intake, data entry, and patient communication—allowing pharmacy teams to shift their focus back to patient care and clinical decision-making.  Through the lens of both operator and innovator, the discussion explores how AI is not replacing pharmacy professionals, but augmenting them—reducing burnout, improving accuracy, and enabling scalable growth. With automation handling up to the majority of repetitive workload and delivering measurable ROI, TJM Labs represents a new model where technology and pharmacy expertise work together to create more efficient, patient-centered operations. 

Guests: Gil Bashe Chair Global Health and Purpose at FINN Partners Maya Hajizada Chief Revenue Officer at Rx2Go C. Daniel Mullins Professor at University of Maryland School of Pharmacy Mina G Yacoub PharmD BCPS Founder & CEO at Qik Productions

TWIRx News: The FDA plans to remove 12 peptide bulk drug substances from Category 2 of the Section 503A compounding list after their nominations were withdrawn. For compounders, the key issue is that this change does not automatically make compounding these substances permissible, leaving pharmacies exposed to ongoing regulatory uncertainty until the FDA makes further decisions. A nationwide Class II recall has been issued for Xanax XR 3 mg tablets in 60-count bottles, lot 8177156, after the product failed dissolution testing. Pharmacists should immediately locate and quarantine affected stock while reminding patients not to stop benzodiazepine therapy suddenly without direction from a healthcare provider. Community pharmacies are taking on a larger role in wound care by serving as an accessible first point of contact for patients with minor injuries. Pharmacists can help assess wounds, recommend appropriate over-the-counter treatment, watch for warning signs of complications, and refer patients for higher-level care when needed. Special sponsor interview with Allison Arant with Clearway Health.  Featured interview with  the World's Leading Innovation Theorist John Nosta Guests & sponsors of today's TWIRx, Perigon 360 Pharmacy with Chris Antypas PharmD and ed Mills  And a bonus interview with Dr. Andy Krut PharmD, on Psychedelics (e.g., LSD, psilocybin, DMT)

This Week in Pharmacy 04-10-2026 Sponsored by Outcomes and Independent Pharmacy Cooperative (IPC) On this episode of This Week in Pharmacy, we dig into another high-impact week across the profession with TWIRx news, practice transformation, oncology leadership, pediatric research innovation, and a look ahead to one of specialty pharmacy’s biggest gatherings of the year. This week’s episode is powered by our sponsors, Outcomes and Independent Pharmacy Cooperative (IPC), organizations continuing to support independent pharmacy innovation, patient engagement, and pharmacy performance. In the TWIRx News segment, we cover four important stories shaping the national conversation in pharmacy. First, we discuss the federal fraud case involving a Dearborn Heights pharmacy owner who pleaded guilty in a $1.9 million health care fraud scheme. According to the U.S. Department of Justice, Rabih Hamdan admitted to conspiring to submit false claims for prescription drugs that were either medically unnecessary or never actually dispensed, impacting Medicare, Medicaid, and Blue Cross Blue Shield of Michigan. Federal prosecutors say the fraudulent claims totaled at least $1.9 million over a five-year period. Next, we look at oncology pharmacy leadership through the lens of Amy Seung, who is stepping into the HOPA presidency during a period of rapid acceleration in cancer care. In Pharmacy Times, Seung describes a practice environment where new approvals, indications, toxicity data, and clinical questions are arriving weekly or even daily. She positions HOPA as a key bridge between emerging science and real-world implementation, with this year’s conference emphasizing bispecific therapies, real-world evidence, supportive care, and toxicity management. We also spotlight a powerful research update from the UNC Eshelman School of Pharmacy, where professor David Drewry and student researchers are advancing work on diffuse intrinsic pontine glioma (DIPG), an aggressive pediatric brain cancer with limited treatment options and an average life expectancy of about one year after diagnosis. The team is using an open-science model to accelerate discovery while keeping future therapies more affordable, and they are working with M4K Pharma to advance an ALK2 inhibitor toward a Phase 1 clinical trial. Finally, we feature a practice transformation story from Drug Topics: Gregg Jones, MBA, RPh, made the leap from corporate pharmacy leadership to launching Compass Core Pharmacy, described as Rhode Island’s first cost-plus pharmacy model. The cash-only model focuses on generics, uses AI-driven ordering, serves a growing veterinary segment with more than 1,400 pet prescriptions, and operates as a CLIA-waived pharmacy offering point-of-care testing. It is a compelling example of how pharmacists are reengineering care delivery outside the traditional reimbursement framework. We are also getting ready for Asembia 2026 in Las Vegas, where the Pharmacy Podcast Network will once again provide press coverage with support from Clearway Health. You can find us at booth 1805, where we’ll be capturing conversations that matter across specialty pharmacy, access, patient support, innovation, and care delivery. Our first featured interview is with Nick Baird, Director of Marketing with Outcomes, where we will explore the growing role of pharmacy engagement, patient activation, and value creation in community-based care. Our second interview features Dr. Jen Hammons, PharmD, DrPH, with Health Wagon, a vital community healthcare organization dedicated to serving medically underserved patients through an expanding network of care. In 2024 alone, Health Wagon served 7,291 unique patients through 21,615 patient encounters, supported by five mobile health units, three stationary clinic sites, a dental clinic, a vision clinic, and a pharmacy. Known for hosting one of the nation’s largest health outreach efforts of its kind, Health Wagon continues to expand its impact through the dedication of staff, volunteers, trustees, partners, donors, and supporters. Join us as we connect the week’s top headlines to the broader transformation underway in pharmacy practice, policy, specialty care, and community health. To learn more, follow the Pharmacy Podcast Network and stay connected as we head into Asembia 2026.

TWIRx – April 3, 2026 Co-Host: Jesse McCullough On today’s episode of This Week in Pharmacy – TWIRx, we welcome special co-host Jesse McCullough for a timely discussion focused on pharmacy innovation, compliance, advocacy, and the future of the profession. We begin with our featured sponsor segment presented by MatchRx, spotlighting two important voices in pharmacy technology and compliance. Johny Kello, CEO of MatchRx, joins the show alongside Riya Cao, CEO of LSPedia, for an important conversation centered on DSCSA readiness and the evolving world of pharmacy compliance. This discussion explores how pharmacies and supply chain stakeholders can better prepare for regulatory expectations, protect patients, and strengthen operational transparency through smarter compliance solutions. In the second half of the episode, we’re joined by Scott Brunner, CEO of the Alliance for Pharmacy Compounding (APC), for a recap of the Owner Summit 2026 and a look ahead at what’s developing on Capitol Hill. Scott shares insight into the policy landscape impacting pharmacy compounding, the priorities emerging from this year’s summit, and what pharmacy owners and industry leaders should be watching as legislative and regulatory conversations continue to evolve. This episode of TWIRx delivers a strong pulse on the profession—from compliance and interoperability to advocacy and the future of compounding pharmacy. Featured Guests: Johny Kello, CEO, MatchRx Riya Cao, CEO, LSPedia Scott Brunner, CEO, Alliance for Pharmacy Compounding (APC) Episode Topics: DSCSA and pharmacy compliance Supply chain visibility and readiness MatchRx and LSPedia collaboration in pharmacy compliance Owner Summit 2026 recap Capitol Hill updates impacting pharmacy compounding The future of compounding and pharmacy advocacy Sponsored by: MatchRx DSCSA Compliance and Compounding Leadership | TWIRx 

This episode is dedicated to the late Dr. Eric Geyer PharmD.  Feautured guest Chuck Melendi Disruptive Dialogue Special report from Bruce Kneeland Sponsored by TJM Labs and interview with Jonathan Adly This episode is sponsored by YARAL Pharma 

On this week’s This Week in Pharmacy (TWIRx), we explore how innovation, technology, and emerging therapies are reshaping pharmacy practice. From the growing influence of AI in medical information research, to the next generation of pharmacy management systems, and the expanding role of cell and gene therapies, this episode brings together industry leaders to discuss what’s next for pharmacy. Special thanks to this week’s sponsors Cardinal Health, Independent Pharmacy Cooperative (IPC), and Nested Knowledge for supporting the podcast. Segment 1 – AI & the Future of Medical Information with Nested Knowledge Nested Knowledge returns to TWIRx as we welcome back Keith Kallmes, Co-Founder of Nested Knowledge, for an update on how artificial intelligence is transforming the way healthcare professionals access and interpret medical information. Keith explains how AI-powered tools are improving evidence synthesis, systematic literature reviews, and clinical decision support, helping researchers and clinicians navigate the growing volume of medical literature while enabling faster, more reliable insights. Segment 2 – The Evolution of Pharmacy Management Systems with Outcomes Next, we’re joined by Lou Ann Myers from Outcomes to discuss how pharmacy management systems are evolving beyond traditional dispensing. Modern pharmacies require integrated technology connecting billing, treatment planning, clinical tracking, inventory management, and revenue-generating services. Lou Ann shares why these systems must support both clinical services and business sustainability as pharmacies expand into value-based care and new service models. Segment 3 – Emerging Therapies with Cardinal Health In our final segment, we welcome Dr. Fran Gregory, PharmD, Vice President of Emerging Therapies (Cell & Gene, Biosimilars) at Cardinal Health, to discuss one of the most transformative areas in healthcare. Dr. Gregory explores the growing impact of cell and gene therapies and biosimilars, and what these innovations mean for pharmacists, health systems, and specialty pharmacy providers as the industry prepares for new challenges in distribution, access, and reimbursement. About TWIRx (This Week in Pharmacy) TWIRx is the flagship news and commentary podcast from the Pharmacy Podcast Network, delivering weekly insights on the business, technology, and policy shaping the pharmacy profession.

Welcome to another episode of TWIRx – This Week in Pharmacy, where we break down the most important developments impacting the pharmacy profession. This week’s show features leaders from across community pharmacy, health systems, healthcare advocacy, and international patient engagement. From PBM reform to patient-centered care and health system growth in Western Pennsylvania, this episode brings together voices shaping the future of pharmacy. Sponsored by Sykes & Company, P.A. Accounting, tax strategy, and advisory services dedicated exclusively to independent pharmacy operators. Segment 1 Austin Murray Communications and Marketing Director – Sykes & Company, P.A. We kick off TWIRx with Austin Murray from Sykes & Company, discussing the NCPA Consumer Marketing Campaign designed to educate the public about the value of community pharmacies. Austin shares insights on: • The importance of telling the community pharmacy story directly to consumers • Why independent pharmacies remain essential healthcare access points • The evolving state of independent pharmacy nationwide • Continued momentum around PBM Reform • Strategic accounting and tax advantages pharmacy operators should understand in today’s challenging reimbursement environment Austin also explains how pharmacy-focused accounting firms like Sykes & Company help owners navigate reimbursement pressure, tax planning, and business strategy. Segment 2 Mark Duman Pharmacy 50 Award Winner – United Kingdom International healthcare thought leader Mark Duman joins TWIRx to discuss one of the most important principles in healthcare transformation: The patient must come first. Mark shares his perspective on: • Why healthcare systems must remain patient-centered • How pharmacy can lead the way in improving patient outcomes • Lessons learned from patient engagement initiatives in the UK healthcare system • Why meaningful healthcare innovation always begins by focusing on the patient experience Mark emphasizes that when healthcare professionals keep the patient as the constant focus, better pharmacy care and stronger health systems follow. Segment 3 Dr. Laura Mark, PharmD Vice President of Pharmacy – Allegheny Health Network Next, we welcome Dr. Laura Mark, Vice President of Pharmacy at Allegheny Health Network (AHN), who shares exciting news about new pharmacy operations facilities recently built in Butler County, Pennsylvania. Todd and Laura also reflect on their shared roots growing up in Butler County, while discussing how AHN is investing in the future of pharmacy. Topics include: • The new pharmacy operations infrastructure in Western Pennsylvania • How AHN is expanding pharmacy services across the Greater Pittsburgh region • The role of health system pharmacy in improving access to care • Strategic positioning for future healthcare growth and integration AHN continues to strengthen its pharmacy operations as a key component of coordinated patient care throughout the region. Segment 4 Eric Pusey Independent Pharmacy Owner – Pennsylvania Closing out this week’s episode, pharmacy owner Eric Pusey joins TWIRx to discuss the latest updates on PBM Reform in Pennsylvania. In 2024, Pennsylvania enacted Act 77, a landmark law aimed at increasing oversight and fairness in pharmacy benefit management. Eric explains how the law: • Grants new regulatory authority to the Pennsylvania Insurance Department • Restricts PBM patient steering to pharmacies owned or affiliated with benefit managers • Improves transparency requirements for PBM operations • Establishes payment protections intended to level the playing field for community pharmacies Patient steering practices have long limited competition and reduced patient choice. Eric shares why these reforms represent an important step toward protecting both patients and independent pharmacy providers across the Commonwealth. Listen & Subscribe Stay informed on the business, policy, and innovation shaping the pharmacy profession. Follow TWIRx – This Week in Pharmacy on the Pharmacy Podcast Network, featuring conversations with the leaders and advocates advancing pharmacy practice.

On this episode of This Week in Pharmacy, we spotlight two major conversations shaping the future of pharmacy practice in 2026. First, we welcome Dr. Lisa Faast, PharmD, founder of DiversifyRx, to discuss the Pharmacy Profit Summit 2026 and how independent pharmacies can strengthen margins, diversify revenue streams, and build sustainable growth models in today’s reimbursement environment. Then, we turn to Rare Disease Day 2026 with Richard Faris PharmD, Chief Commercial & Clinical Officer at and PANTHERx Rare, to discuss specialty pharmacy leadership, pharmacist impact, and new patient feedback data revealing communication gaps in rare disease care. Segment 1: Pharmacy Profit Summit 2026 Guest: Dr. Lisa Faast, PharmD | Founder, DiversifyRx Dr. Faast joins us to break down the vision behind Pharmacy Profit Summit 2026 — an event designed to equip pharmacy owners with practical strategies to increase profitability while maintaining clinical excellence. Key Topics Covered: • Why independent pharmacies must move beyond traditional dispensing revenue  • Diversification strategies including niche services and high-value offerings  • Real-world financial benchmarks pharmacy owners should track  • How mindset, leadership, and data discipline drive sustainable profitability  • The importance of collaboration and shared intelligence among pharmacy entrepreneurs The Pharmacy Profit Summit is not just about revenue — it’s about equipping pharmacy owners to compete intelligently in a rapidly consolidating healthcare market. Segment 2: Rare Disease Day 2026 Guest: Richard Faris, PharmD | PANTHERx Rare In recognition of Rare Disease Day 2026, we are honored to welcome Richard Ferris, PharmD, to discuss the critical role pharmacists play in specialty pharmacy and rare disease care. PantherRx recently released survey findings examining patient and caregiver experiences within rare disease treatment journeys. Key Study Highlights: • 90% of patients and caregivers report delays due to communication gaps  • 68% report waiting for updates from providers, pharmacies, or insurers  • 90% say they manage the care process themselves  • 72% desire a dedicated care coordinator  • 73% agree it is unclear who is responsible for coordinating rare disease care Despite advances in specialty therapeutics, patients are still asking for the fundamentals: clear communication, coordinated care, and personalized support. Richard discusses: • The growing importance of specialty pharmacists as care coordinators  • Why rare disease patients often feel burdened by system fragmentation  • How specialty pharmacy can close communication gaps  • The need for pharmacist-led continuity in complex therapy management Rare Disease Day reminds us that specialty pharmacy is not only about high-cost medications — it is about human connection, long-term coordination, and advocacy for patients navigating some of the most complex clinical journeys in healthcare.  From business sustainability to patient-centered specialty care, this episode reinforces two realities: Pharmacy must remain financially strong to survive. Pharmacists must remain clinically present to lead. As the profession evolves, profitability and patient advocacy are not opposing forces — they are interdependent pillars of pharmacy’s future. Listen now and join the conversation shaping Pharmacy in 2026.

LTC Rx at Home: Logistics & Advocacy | TWIRx Rx4Route is a specialized pharmacy delivery management platform and software designed to optimize prescription delivery for pharmacies. It integrates with existing systems to provide real-time tracking, AI-powered route optimization, HIPAA-compliant proof of delivery, and driver management tools. It aims to reduce delivery costs and improve efficiency. Doni Sattarov with Rx4Route Rx4Route.com   Kristen Hutchison - Health Policy and Patient Advocacy As a seasoned medical technical writer and chronic illness patient advocate, I meticulously translate intricate medical information into succinct content tailored for diverse audiences, including engineers, clinicians, educators, and advocacy groups. https://www.khutchison.com/

TWIRx – This Week in Pharmacy Episode Date: February 13, 2026 Valentine’s Day Special 💘 This week on TWIRx, hosts Stephen Beckman, PharmD and Todd Eury break down the biggest headlines shaping pharmacy, from workforce trends to policy updates and innovation. 💕 Valentine’s Feature: TogetheRx – A Pharmacy Love Story In celebration of Valentine’s Day, we welcome Drs. Mark and Gretchen Garofoli, PharmD, a pharmacy power couple who met at the University of Pittsburgh School of Pharmacy and have built a life and career TogetheRx. Their journey includes raising a family, leading in pharmacy advocacy, podcasting, academic work with WVU School of Pharmacy, and operating a community pharmacy near Morgantown, WV. 🧪 Love Potion Segment: A Historical Rx Dr. Mark Fulton, PharmD, host of the RxTales Podcast, joins the show to explore the surprising history of “love potions” and how folklore intersects with early pharmacy and medicine. 🚀 Innovation Spotlight: RxTransfer & Interoperability We close with Pharmacy 50 Award Winner Alumni 2025, Dr. Lawrence King, PharmD, VP of Product Innovation at Surescripts, discussing RxTransfer, prescription interoperability, and how technology is modernizing pharmacy workflow and patient safety. ❤️ From love stories to pharmacy innovation, this Valentine’s edition celebrates the profession from the heart. Subscribe, listen, and share as we head into Valentine’s Day 2026.  

 Independent pharmacies are dispensing more prescriptions than ever—but too many are seeing their profits shrink month after month. In this episode of This Week in Pharmacy, hosts Todd Eury and CEO of MatchRx Johny Kello sit down with Saeed Dinno Director of Pharmacy for a group of independent pharmacies in MI. For a practical, plain-English breakdown of one of the most overlooked metrics impacting pharmacy profitability: GCR, let's dive into this! This episode isn’t about policy debates, compliance theory, or vendor hype. It’s a real-world conversation designed to help pharmacy owners, managers, and buyers understand how everyday sourcing and dispensing behaviors directly influence margin—often without anyone realizing it. Saeed explains what GCR actually measures, what it does not measure, and why two pharmacies filling the exact same prescription can end up with completely different financial outcomes. From convenience buying and emergency orders that become routine, to default NDC selection and a disconnect between the buyer and the bench, the episode highlights the subtle habits that quietly erode profitability over time. More importantly, the conversation delivers actionable steps pharmacies can implement immediately. Saeed outlines the core disciplines that improve performance—smarter buying strategy, better alignment between purchasing and dispensing, and simple operational guardrails that don’t slow workflow. The focus is not on “working harder,” but on working differently. The episode closes with a clear, clip-worthy takeaway: one specific action pharmacy leaders can take this month to start moving the needle. If you’ve ever wondered why your pharmacy is busy but the numbers don’t reflect it, this is an episode you’ll want to listen to twice—and put into practice the very next day. Second segment of TWIRx is with Jonathan Adly, CEO of TJM Labs, to discuss his powerful new book, The Innovative Pharmacy: How to Build an 8-Figure Pharmacy One Idea at a Time. At a time when independent pharmacies are being squeezed by rising labor costs, shrinking reimbursements, and increasing operational complexity, Adly delivers a refreshing message: success is still possible—but it requires innovation, clarity, and execution. Jonathan shares why this book is not a “one-size-fits-all” business blueprint, but a collection of real-world frameworks inspired by hundreds of high-performing pharmacies across the U.S. and Canada. We explore the principles behind sustainable growth, including identifying your ideal customer, building scalable systems through automation, simplifying operations, and playing offense when the math works. This conversation is a call to action for pharmacy leaders ready to build smarter, faster, and stronger—one bold idea at a time. This episode of TWIRx is sponsored by MatchRx, TJM Labs, Independent Pharmacy Cooperative (IPC) and Sykes & Company. 

TWIRx – January 30 | Special Guest: Marc Essensa, CEO of IPC On this episode of This Week in Pharmacy, we welcome Marc Essensa, President and CEO of the Independent Pharmacy Cooperative (IPC), to discuss timely strategies and resources helping independent pharmacies strengthen their businesses in today’s challenging environment. Building Your Independent Pharmacy Business Marc shares insights on navigating reimbursement pressure, improving margins, and leveraging IPC’s purchasing power, data, and strategic tools to support long-term sustainability. The Payment Card Settlement: A Practical Guide We break down IPC’s guidance on the Payment Card Interchange Fee Settlement, which may allow pharmacies that accepted Visa or Mastercard between 2004–2019 to recover funds. Marc explains eligibility, next steps, and how recovered dollars can support cash flow, staffing, technology, or inventory investments. IPC Member Support Services The conversation highlights IPC’s expanded member support offerings, including business consulting, strategic partnerships, wholesale access, and operational resources designed to help independents stay competitive. Legislative & Advocacy Updates Marc also provides updates on IPC’s advocacy efforts at both the state and federal levels, focused on protecting independent pharmacy interests and addressing ongoing policy and reimbursement challenges. 🔗 Resource Mentioned The Payment Card Settlement: A Practical Guide – IPC https://www.ipcrx.com/pharmacy-blog/news/the-payment-card-settlement-a-practical-guide/ Special guest:  Sakhi Gaurang Patel is a trailblazing PharmD candidate at the UC Irvine School of Pharmacy & Pharmaceutical Sciences and a co-founder of the startup CuraVoice. Recognized for her work in healthcare equity, mentorship, and educational technology, she focuses on improving patient communication and reducing health disparities. Featured Guest: Dr. Jenny Newlon, PharmD — Researcher and Pharmacist with Birth Control Pharmacist In this episode of This Week in Pharmacy, we sit down with Dr. Jenny Newlon to explore how pharmacist consultants, health clinics, and independent pharmacies can build high-value contraception services that meet urgent community needs. We discuss practical strategies for delivering accessible birth control care—especially in areas that have lost Planned Parenthood centers—while creating new revenue models outside the constraints of traditional PBM reimbursement. Dr. Newlon breaks down: How pharmacies can implement contraception services—even with limited staff or clinical infrastructure Ways to deliver value to patients and communities through education, access, and continuity of care Forward-thinking business models that diversify revenue beyond dispensing Tune in to learn how independent pharmacy teams can lead with care, expand women’s health access, and strengthen their role as trusted healthcare providers. Today's "This Week in Pharmacy" is sponsored by Independent Pharmacy Cooperative (IPC)

In this episode of This Week in Pharmacy, we explore how the Pharmacy Podcast Network (PPN) is deepening connections across healthcare by elevating pharmacists’ voices in the conversations that matter most. Inspired by the recent partnership between podcasting giant PodcastOne and the AI-driven analytics platform Listener, we highlight how PPN is using the same type of advanced engagement metrics—combining podcast listener data, social media signals, and network insights—to measure true influence, not just downloads.  With Listener’s powerful data, PPN can now identify where pharmacists are making the greatest impact and uncover new opportunities to expand pharmacist positioning with other providers, industry leaders, and the public. Plus, Todd sits down one-on-one with Kris Rhea of Pharmacy Market Place for an insightful conversation on AI in pharmacy—exploring how artificial intelligence is shaping workflow, clinical decision-making, business operations, and what pharmacists need to know to stay ahead in a rapidly changing healthcare landscape.

🎙️ This Week in Pharmacy (TWIRx) — January 9, 2026 Welcome to TWIRx — This Week in Pharmacy! I’m your host Todd Eury, and today’s episode is sponsored by YARAL Pharma, a generics company committed to “Doing Things Differently”—with a human-centered, untraditional approach that’s redefining relationships between industry and pharmacy practice.  ✅ Today’s Sponsor: YARAL Pharma YARAL Pharma is committed to innovation, partnership, and supporting pharmacists at the front lines—especially as healthcare continues to restructure and the role of the pharmacist becomes more essential than ever. Their mission to Do Things Differently is more than a slogan—it’s a commitment to reshaping what a generics company can stand for in today’s healthcare marketplace.  📰 This Week in Pharmacy — News 1) Amazon Pharmacy to Offer Novo Nordisk’s Wegovy Pill Nationwide Amazon Pharmacy is now offering Novo Nordisk’s newly FDA-approved Wegovy pill, making the weight-loss medication available nationwide through both insurance coverage and cash-pay options. This move continues Amazon’s expansion into digital healthcare access—bringing blockbuster GLP-1 therapies directly to consumers and increasing competition among major pharmacy providers. https://www.mobihealthnews.com/news/amazon-pharmacy-offer-novo-nordisks-wegovy-pill 2) Dr. David Pope: AI, Online Pharmacies, and Why the Neighborhood Pharmacist Still Wins Trust In a must-read guest column, Dr. David Pope argues that while AI and online pharmacy services are rapidly surging, the community pharmacist remains one of the most trusted healthcare professionals in America. He points to how pharmacy deserts, increasing reimbursement pressure, and policy reform will reshape pharmacy in 2026—and why the profession’s future will depend on protecting and empowering local pharmacy care. https://drugstorenews.com/ai-and-online-pharmacy-surge-neighborhood-pharmacist-remains-most-trusted  3) Pharmacist Leadership Spotlight: Illuminate Rx Names Ritu Malhotra, PharmD, as President Illuminate Rx announced the appointment of Ritu Malhotra, PharmD, as its new President, reinforcing the growing trend of pharmacists stepping into leadership roles across pharmacy benefits and PBM reform. With decades of experience modernizing healthcare and pharmacy benefit strategy, Malhotra’s appointment signals Illuminate Rx’s focus on improving transparency and clarity in pharmacy benefits management. https://www.prnewswire.com/news-releases/illuminate-rx-appoints-industry-veteran-ritu-malhotra-pharmd-as-president-to-advance-clarity-in-pharmacy-benefits-302657441.html 4) Viatris Exec David Marin Named New CEO of PCMA The Pharmaceutical Care Management Association (PCMA)—the leading PBM trade group—has named David Marin, previously Head of Global Government Affairs & Public Policy at Viatris, as its next President and CEO effective January 30, 2026. His selection comes at a pivotal time as PBMs face rising scrutiny and intensifying policy pressure nationwide. https://www.healthcaredive.com/news/pcma-names-new-ceo-david-marin/809158/  🎤 Interviews & Segments ⭐ Segment 1 — Special Sponsor Interview Stephen Beckman, CEO of YARAL Pharma We kick off TWIRx with a special conversation featuring Stephen Beckman, CEO of YARAL Pharma, exploring what 2026 has in store for pharmacy and healthcare. We discuss the Pharmacy 50 Awards, the importance of honoring leadership across the profession, and why supporting pharmacists right now—during one of the most fragile and transformative moments in U.S. healthcare—is absolutely critical. ⭐ Featured Interview — Pennsylvania State Representative Rep. Charity Grimm Krupa — 51st Legislative District Today’s featured interview is with State Representative Charity Grimm Krupa, who represents Pennsylvania’s 51st Legislative District in the House of Representatives. We discuss real healthcare issues impacting Pennsylvanians—including medical cannabis, small business healthcare benefit strategies, and why it’s essential for healthcare professionals to stay connected with their state lawmakers. Rep. Krupa also shares why every citizen should aim to communicate with their own representatives at least once per year. ⭐ Segment 2 — Clinical & Policy Spotlight Dr. Sally Rafie, PharmD — “The Birth Control Pharmacist” In our second segment, we welcome Dr. Sally Rafie, PharmD, nationally known as the “Birth Control Pharmacist.” Dr. Rafie is a clinical pharmacist specialist at UC San Diego Health and an assistant clinical professor at the UC San Diego Skaggs School of Pharmacy, widely recognized for advancing pharmacists’ role in reproductive health care. She is also the founder of Birth Control Pharmacist, an education and training company that equips pharmacists and healthcare teams to prescribe and deliver contraception care through evidence-based resources, clinical updates, and advocacy support—helping expand access to contraception through pharmacies nationwide. 🔔 Closing That wraps up this week’s episode of This Week in Pharmacy. Thanks for tuning in—and thank you again to YARAL Pharma for sponsoring today’s TWIRx. If you enjoyed today’s episode, please share it with a fellow pharmacist, leave a review, and stay connected as we continue to cover the stories shaping the pharmacy profession. See you next week on TWIRx when we celebrate the "50 Most Influential People in Pharmacy" Awards LIVE!! 

Happy New Year 2026 | TWIRx    Happy New Year to our listeners, our hosts, our sponsors, and all of our supporters, Happy New Year to a PROSPEROUS 2026. We're joined by CEO of YARAL Pharma, Stephen Beckman to talk about the coming challenges in pharmacy and how pharmaceutical manufacturing can become a stronger ally to the pharmacist and the pharmacy profession. New from Pharmacy Times, Tradipitant Becomes First Treatment Approved for Vomiting Due to Motion Sickness in 4 Decades. News from Drug Topics, Pharmacists Can Use Social Media for Professional, Educational Advancement News from Signal Akron, PPRx: A local pharmacy supporting reproductive health care in Ohio Check out GetPRISMRx.com for more information how to build your own contraception patient treatment program, with this new tech!!  #Pharmacy 50 Awards coming to TWIRx January 16th, 2PM LIVE

Up first, Inspirogene-by-McKesson with Joe DePinto   InspiroGene" is a dedicated business unit launched by McKesson in October 2024, focused solely on supporting the commercialization of cell and gene therapies (CGTs). It leverages McKesson's expertise in supply chain, logistics, and specialty pharmacy to help manufacturers, payers, and providers navigate the complex CGT landscape. https://www.mckesson.com/business-solutions/our-businesses/inspirogene-by-mckesson/ Our featured interview: Sponsored by MatchRX The TrumpRx Playbook for Independent Pharmacies CEO of MatchRx Johny Kello co-hosts with Todd Eury featuring our guest speaker, Dae Lee, Pharm.D., Esq., CPBS. Dae is a pharmacist-attorney and a Shareholder in the FDA & Biotechnology practice at Buchanan Ingersoll & Rooney. What makes Dae especially valuable for this conversation is that he’s not just reading policy from 30,000 feet — he represents pharmacies every day in high-stakes fights with PBMs, from audits and reimbursement disputes to network suspensions and terminations. So, when we talk about TrumpRx — how it works, what it could break, and what independents should do next — Dae can translate the legal and contracting reality into real-world consequences behind the counter. Connect with MatchRX: MatchRX.com Special Message from Greg Reybold with APCI, update of the "Pharmacists Fight Back Act" Connect with Greg: https://www.apcinet.com/ Next, we talk with Dr. Jessica Daley PharmD Fractional Supply Chain and Operations Executive, with Pharma Logistics, we dicuss drug shortages and strategies for 2026. Connect with Jessica: https://www.linkedin.com/in/jessicaldaley/ Last interview, a suprise message from International Pharmacy 50 Pharmacist & Author Katrina Azer, announcing her new book  https://www.katrinaazer.com/#books

Segment 1: The Hidden Lender in America’s Drug Supply Chain Guests: Antonio Ciaccia, President, 3 Axis Advisors Alec Ginsberg, Founder, The Drugstore Cowboy Building on Alec Ginsberg’s investigative article, “The Hidden Lender in America’s Drug Supply Chain,” this discussion exposes how capital flows, credit structures, and opaque financial relationships influence pharmacy viability. Ciaccia and Ginsberg break down what independent pharmacists need to understand about who truly controls leverage in the system—and why transparency matters more than ever. Segment 2: How AI Is Transforming Pharmacy Operations Guests: Harry Travis, BS Pharm, MBA, President, The Travis Group Amanda Awe, PharmD, Clinical Product Consultant, Curatio Advisors Artificial intelligence is no longer theoretical in pharmacy—it’s operational. This segment explores how AI is being deployed today to improve workflow efficiency, clinical decision-making, and patient engagement, while addressing the real-world challenges of adoption. Inside the Forces Reshaping America’s Drug Supply Chain | TWIRx    Thanks to NimbleRx, PRISM by OvaryIT, and Sykes & Company for sponsorsing today's show

 This Week in Pharmacy – Friday, December 5th Strengthening the Pharmacy Workforce: A Conversation with Crystal Lennartz Cutting Through the AI Confusion: Shaun Jensen on Smarter Pharmacy Operations The New 340B Reality: Allison Arant on Navigating HRSA’s Rebate Model Welcome to another episode of This Week in Pharmacy, where we bring together the most important conversations, industry insights, and breaking pharmacy news shaping the future of healthcare. Today’s show features a powerhouse lineup of leaders driving innovation across retail pharmacy, technology, consulting, and 340B health-system strategy. 🟦 Segment 1 — Interview with Crystal Lennartz, President of Health Mart & Health Mart Atlas We open the show with a conversation with Crystal Lennartz, President of Health Mart and Health Mart Atlas, about the evolving role of workforce management in independent pharmacies.  📰 TWIRx News — Friday, December 5th A fast roundup of the top stories impacting pharmacy this week: 👉 Humana Exploring Partnership with Mark Cuban Humana is reportedly in discussions with Mark Cuban to explore a potential pharmacy partnership that could disrupt traditional PBM and drug-supply models. The collaboration may reshape how medications are priced and accessed—another sign that alternative pharmacy models are gaining traction. 👉 New Migraine Therapy: Symbravo Pharmacists should be aware of Symbravo, a new dual-action migraine therapy combining meloxicam and rizatriptan. Importantly, the product is non-substitutable, meaning pharmacies must dispense exactly as written. The therapy adds a new tool for acute migraine care but requires careful patient counseling on cardiovascular risks, medication-overuse headaches, and NSAID interactions. 👉 Walgreens Expands Automated Fulfillment Centers Walgreens continues restructuring by expanding its automated micro-fulfillment pharmacy network. Robots are now filling a growing percentage of maintenance prescriptions, allowing pharmacists to refocus on clinical services. The move signals accelerating automation across retail pharmacy as chains seek cost savings and operational efficiency. 🟦 Segment 2 — Interview with Shaun Jensen, CEO of JB Consulting Group Next, we speak with Shaun Jensen, CEO of JB Consulting Group, about the rising confusion many pharmacy operators face around AI adoption. We discuss: Where AI adds true efficiency versus where it’s misunderstood Practical steps for pharmacy owners to implement AI tools How data-driven automation can improve workflow, inventory, prior authorizations, and patient communication The mindset shift required for pharmacies to thrive in an AI-supported future 🟦 Segment 3 — Interview with Allison Arant, SVP of Client Development & Marketing, Clearway Health Our final interview is with Allison Arant from Clearway Health, focusing on the new challenges hospital systems face as HRSA launches the 340B rebate model. Key discussion points: How the rebate model changes operational and financial dynamics for 340B hospitals Why safety-net hospitals caring for large uninsured and underinsured populations are feeling heightened pressure Strategies Clearway Health is deploying to help health systems navigate rising medication costs, compliance demands, and shrinking margins What health-system pharmacies must prepare for heading into 2026 This week’s conversations underscored a unifying theme: the pharmacy industry is entering a period of rapid transformation, driven by new reimbursement models, automation, innovation partnerships, and evolving expectations from both patients and payers. Independent pharmacies, health systems, and specialty operators all face challenges—but also significant opportunities for reinvention, collaboration, and leadership. Thank you for tuning in to This Week in Pharmacy. Stay informed, stay inspired, and keep pushing our profession forward.   Walgreens doubles down on automation to reshape pharmacy operations. The retail pharmacy giant is dramatically expanding its network of robot-powered micro-fulfillment centers (MFCs) — facilities that dispense maintenance medications for chronic conditions like diabetes and hypertension. The goal: serve 5,000+ stores by the end of the year, up from earlier coverage of around 4,800 stores. https://chainstoreage.com/news-briefs/2025-12-05?article=walgreens-expands-automated-pharmacy-fulfillment-network New migraine therapy raises key practice questions for pharmacists. Symbravo — a fixed-dose oral tablet combining meloxicam (an NSAID) and rizatriptan (a triptan) — has been approved for the acute treatment of migraine with or without aura, offering a dual-mechanism option targeting both inflammation and serotonin-mediated pathways.  Pharmacists now play a critical role: they must identify patients at risk for medication-overuse headaches, screen for contraindications (e.g., cardiovascular disease, GI risk, or NSAID/triptan interactions), and advocate for comprehensive migraine management beyond just pain relief — including lifestyle adjustments and referrals when needed. https://www.pharmacytimes.com/view/what-pharmacists-should-know-about-symbravo-s-role-and-non-substitutability-in-migraine-care  Humana is reportedly working with Mark Cuban on a potential pharmacy partnership — a development that could shake up how prescriptions are delivered and disrupt traditional middle-man models.  The collaboration would leverage Cuban’s innovative approach to drug pricing and distribution, potentially creating a new channel for medication access that bypasses traditional pharmacy benefit managers (PBMs) and large-chain dispensaries. If executed, the partnership could increase competitive pressure on legacy players and reshape the pharmacy supply chain.  For independent pharmacies and pharmacy leaders, this signals a possible shift in how drugs are sourced, priced, and distributed — highlighting the growing influence of alternative pharmacy models and urging traditional pharmacies to adapt or risk being left behind. https://www.bloomberg.com/news/articles/2025-12-04/humana-working-with-mark-cuban-on-potential-pharmacy-partnership   Washington, DC there's a whole bunch of pharmacy people meeting up to rollout the Pharmacists Fight Back Act (PFBA)! If you want to go, LISTEN UP!! You’ll be joining pharmacists and pharmacy owners from more than 17 states, all calling for meaningful pharmacy reimbursement reform NOW. Your presence at the news conference will send a strong message to your Congressional Delegate: "we’re serious about passing legislation that protects and keeps pharmacies in business."  The news conference is scheduled for Thursday, December 11th at 9:30 AM on the Capitol Hill lawn. Meet up with "Pharmacists United for Truth and Transparency".   Check out TRUTH RX dot org. We put a link in today's show notes. Check it out or reach out to Todd on LinkedIn. TruthRx.org    The New Pharmacy Playbook: Workforce Strength, AI Clarity, and 340B Reform | TWIRx 

We Give Thanks to You in Pharmacy | TWIRx  Welcome to This Week in Pharmacy for November 28th! We hope you all had a wonderful Thanksgiving, and as we roll into Black Friday, we want to take a moment to express something truly important: our gratitude. At the Pharmacy Podcast Network, we are incredibly thankful for the pharmacists, pharmacy technicians, and pharmacy teams who show up every day for their communities. You are the medication experts, the problem-solvers, the late-night troubleshooters, the vaccine champions, the trusted faces behind the counter, and the advocates who keep patient care moving—often without enough recognition. To every pharmacist and pharmacy technician working long hours, covering holiday shifts, managing medication shortages, answering tough questions, and supporting patients with compassion: Thank you. Your commitment keeps the healthcare system steady, especially during the busiest times of the year. From all of us at the Pharmacy Podcast Network, we appreciate you, we support you, and we’re honored to share your stories. Happy Thanksgiving—and welcome to This Week in Pharmacy. TWIRx News November 28, 2025 Pharmacy Times  Fun Fact: Coffee Could Reduce Feelings of Depression https://www.pharmacytimes.com/view/fun-fact-coffee-could-reduce-feelings-of-depression Saving Advice article “Unmask The Lie: The Reason Your Local Pharmacy Always Runs Out Of Meds” https://www.savingadvice.com/articles/2025/11/28/10442667_unmask-the-lie-the-reason-your-local-pharmacy-always-runs-out-of-meds.html  Could dedicated pharmacists help improve neonatal care’s medicines safety problem? https://pharmaceutical-journal.com/article/feature/could-dedicated-pharmacists-help-improve-neonatal-cares-medicines-safety-problem    On Today's "This Week in Pharmacy" we're welcoming back Pharmacist and Kelli Stovall, RPh EMBA, Vice President of Pharmacy Services and Clinical Programs with IPC. Kelli and I talk about preparing for a more profitable 2026 with several ideas to build new non-PBM revenues with patient services needed throughout communities threatened by 'pharmacy deserts'.  Next, a special feature interview with Myra Ahmad, MD. CEO & Founder of Mochi Health. Mochi Health is a telehealth company offering comprehensive virtual obesity and weight-management services. Through its platform, patients connect with board-certified physicians, nurse practitioners, and registered dietitians to receive personalized treatment plans tailored to their unique body, lifestyle, and health goals.  Mochi Health emphasizes that weight is not a moral failing, but a complex health issue — and their care is non-judgmental and supportive.  Clients can access evidence-based medication options (including GLP-1 receptor agonists), nutrition guidance, and ongoing support — often virtually from home.  The company aims to make obesity care more accessible, affordable, and personalized than traditional in-person clinics.    SPECIAL ANNOUNCEMENT on "This Week in Pharmacy" November 28th 2025, the Legacy Pharmacy Group (LPG) has announced that CEO Ritesh Shah, RPh has been appointed to Governor-Elect Mikie Sherrill’s Transition Task Force in New Jersey. This appointment highlights Shah’s longstanding leadership in independent pharmacy and his commitment to strengthening community-based healthcare across the state. Shah will focus on advocating for independent pharmacies, improving transparency in Pharmacy Benefit Manager (PBM) operations, and promoting policies that ensure community pharmacies remain viable, accessible healthcare resources. His priorities on the task force include: Protecting and strengthening independent pharmacies statewide Ensuring fairness, transparency, and accountability in PBM practices Expanding access and reducing barriers to care, particularly for underserved populations Legacy Pharmacy Group Founder and Pharmacist, Jay Dhaduk, emphasized the importance of having informed pharmacy leadership at the policy level and celebrated Shah’s appointment as critical to the long-term sustainability of independent pharmacies.   The release also highlights LPG’s role as the tri-state area’s largest group purchasing organization, supporting more than 720 independent pharmacy members with programs, services, and advocacy to help them thrive.   Thank you to IPC and YARAL Pharma for sponsoring today's TWIRx  Du2SXEoupKHwm2ROh5lf 

On "This Week in Pharmacy" #TWIRx TWIRx NEWS This Week in Pharmacy News – A trio of developments highlight major shifts and ongoing challenges in pharmacy care: Fruth Pharmacy, a 73-year-old family-owned regional pharmacy chain in West Virginia and Ohio, has been acquired by Walgreens Boots Alliance, with transfer of prescription files and inventory from 16 stores planned for December 3 — the deal underscores how legacy community pharmacies are increasingly consolidating to survive pressure from reimbursement and PBM models. - from Mass Market Retailers https://lnkd.in/emKagG9v At UNC Eshelman School of Pharmacy, the Postgraduate Year One Community-based Pharmacy Residency Program is celebrating 25 years, having trained 163 residents who serve in community pharmacies across North Carolina. With 95 % of Americans living within five miles of a pharmacy, the program emphasizes the critical role of community pharmacists in rural and underserved areas. https://lnkd.in/e-Gk5bkr A new commentary from Those Nerdy Girls draws attention to the growing crisis of “pharmacy deserts” — areas lacking accessible pharmacies — and links closures of independent and chain pharmacies (nearly 1 in 3 since 2010) with inequities in care for rural, Black and Latino-majority neighborhoods. The piece calls for PBM reform, policy action and community engagement to preserve pharmacy access. https://lnkd.in/ezxmdRfb Featured Sponsor today: MatchRX presents: Understanding #DSCSA and the Road to 2026 Special Guest: Ilisa Bernstein PharmD, JD CEO & Co-founder Johny Kello with MatchRX Johny welcomes one of the "50 Most Influential People in Pharmacy", Ilisa B.G. Bernstein, PharmD, JD, to break down the current state of DSCSA compliance as the industry approaches the critical November 2025 enforcement deadline. With decades of leadership in pharmacy practice, regulatory policy, and national advocacy, Dr. Bernstein brings unmatched clarity to what pharmacies must do now — and how the right technology partnerships can keep them operational, efficient, and fully compliant. Learn more: https://www.matchrx.com/ Featured Guest: Dr. Dr. Jordyn Nordé, PharmD, MBA is a forward-thinking clinical hashtag#pharmacist and community leader based in St. Louis who combines advanced clinical training with business acumen to drive impact in underserved populations. With experience in ambulatory care and medication management for conditions like hypertension, diabetes and pain, she is also the founder of an initiative bringing minority pharmacy professionals together through mentorship, entrepreneurship and wellness conversations. Her dual credentials enable her to bridge healthcare, professional development and advocacy — positioning her as an emerging influencer in pharmacy practice transformation.   Du2SXEoupKHwm2ROh5lf

Special Feature:    Andrew Crawford, Vice President at Keysource talks with TWIRx host Todd Eury about the direct to patient market (Direct to Consumer, DTC) expected to hit $21 billion this year. Pharmacy is evolving fast. When DTC brands move in, pharmacies have a choice...compete or collaborate. Some manufacturers are selling directly to patients at discounted cash prices and cutting out traditional intermediaries. The model is projected to grow 9% a year through 2030, with pharma support services expected to nearly double from $3.2B to $5.7B by 2030.  Driven by cost pressure and new legislation, manufacturers are moving quickly. It is creating more transparency but patients still need guidance, trust, and human care. Pharmacy is being redefined as the bridge that keeps care personal, safe, and local. It is not being replaced, but what will it look like in 10 years? TWIRx News:    Pharmacy student shot, killed by friend who became paranoid after they smoked pot together, documents say - from WMTV/Gray News  https://www.wowt.com/2025/11/11/pharmacy-student-shot-killed-by-friend-who-became-paranoid-after-they-smoked-pot-together-documents-say/  Why Guardian Pharmacy Services Stock Was on a Tear Tuesday - by Motley Fool / Yahoo Finance  https://finance.yahoo.com/news/why-guardian-pharmacy-services-stock-202435130.html Metformin May Diminish the Cardiometabolic Benefits of Exercise https://www.pharmacytimes.com/view/metformin-may-diminish-the-cardiometabolic-benefits-of-exercise Today's TWIRx is sponsored by YARAL Pharma & SureCost  

This Week in Pharmacy - November 7, 2025 TWIRx News: First up, Binghamton University School of Pharmacy holds emergency management simulation, VCU Health pharmacies expand access through new home delivery options, and Lilly and U.S. government agree to expand access to obesity medicines to millions of Americans.  Our special guest line up on TWIRx:   Amantha Bagdon - CEO of RxPost  PGX Pharmacist's Protection of Patients with Dr. Melissa Smith PharmD Arkansas HB 1150 TO PROHIBIT A PHARMACY BENEFITS MANAGER FROM OBTAINING CERTAIN PHARMACY PERMITS. with John Vinson CEO of the Arkansas Pharmacy Association & Greg Reybold with APCI  4th Generation Pharmacy Owner C.O. Bigelow (the oldest Apothecary in America) the Drugstore Cowboy, Alec Gingsberg PharmD Thank you to our sponsors:  Independent Pharmacy Cooperative (IPC) Yaral Pharma  SureCost The Drugstore Cowboy Rides Again: PBM Reform in Arkansas & PGx Safeguards for Xeloda Patients | TWIRx

TWIRx in the WORKS!!!  Welcome back to This Week in Pharmacy (TWIRx) — your weekly deep dive into the most important pharmacy news, innovations, and conversations shaping healthcare. In this episode, host Todd Eury brings you stories that move from data to impact, exploring how pharmacists are driving change through knowledge, leadership, and advocacy. 🗞️ TWIRx News Roundup Wrapping up IDWeek 2025 with the latest insights from Pharmacy Practice News and more breaking updates across the profession: 💊 How Well Are You Using Fetroja? Understanding appropriate use of cefiderocol and antibiotic resistance challenges. 🔗 Read at Pharmacy Practice News ⚕️ AFPs Affect Access to Specialty Medications Learn how alternative funding programs are impacting patient access and specialty care. 🔗 Read at Specialty Pharmacy Continuum 🚨 FDA Recall Alert Drug makers recall a blood pressure medicine tainted with a cancer-causing chemical. 🔗 Read the full story via AP News 🧠 Meeting Patients Where They Are How pharmacists are supporting patients managing schizophrenia treatment adherence. 🔗 Read at Pharmacy Times 🎤 Featured Guest: Keith Kallmes President, Nested Knowledge A deep conversation on how Nested Knowledge is transforming the way clinical data becomes actionable insights for healthcare decision-makers. Connect with Keith on LinkedIn 🧬 Today’s TWIRx is sponsored by Nested Knowledge — advancing research automation and evidence synthesis to accelerate medical innovation. 💪 31-Day Pharmacist Challenge A huge thank you to Dr. Jesse McCullough, PharmD — Founder of Keystone Pharmacy Insights — for inspiring the pharmacy community through the 31-Day Pharmacist Challenge during Pharmacist Month! Connect with Jesse on LinkedIn Join his Leadership Community for Pharmacists on SKOOL 🔥 Bonus Guest: Matthew Zachary Principal, Matthew Zachary Worldwide The outspoken healthcare advocate returns to rage against the PBM Mafia, shining a light on the broken business models of the “Big 3” PBMs. Shout-out to Mark Cuban Cost Plus Drugs for disrupting the system and fighting for transparency and affordability for patients everywhere. 📢 Subscribe & Connect Stay tuned to This Week in Pharmacy (TWIRx) for the most relevant stories, data insights, and voices advancing the future of pharmacy care. Follow the Pharmacy Podcast Network on: 🌐 PharmacyPodcast.com 🔗 LinkedIn | X | YouTube | Spotify | Apple Podcasts    Data to Impact: Nested Knowledge & the 31-Day Pharmacist Challenge | TWIRx

Access, Advocacy & Appreciation: The Heart of Pharmacy in Motion --it's time to #TWIRx on October 24th, 2025, it's FRIDAY!! Up first is TWIRx News: From Pharmacy Times, Lynkuet Access Program Aims to Help Women Save on Neurokinin-Targeted Therapy. https://lnkd.in/e2CwGUt8 NEXT from Drug Store News, Pharmacies can close health care gaps for millions while realizing substantial savings for employers A new national study from the Health Action Alliance, commissioned by NACDS, shows pharmacy-based care reduces costs while meeting employee demands for convenient access. https://lnkd.in/eYmrQnHQ NEXT from Open PR, New Research Peptide Supplier Plans Pharmacy Collaborations to Support Licensed Wellness Clinic Sector https://lnkd.in/evkgZtn5 NEXT Study shows alarming drop in pharmacy access in Massachusetts --reporting from WWLP-22News from Boston https://lnkd.in/egWg6G3r In this episode of This Week in Pharmacy, host Todd Eury welcomes featured guest Tiara Green, President of Accessia Health, whose mission is to connect patients without insurance to life-saving medication funding. LINK: https://lnkd.in/gV4VjeZn We also check in with Jesse McCullough for Day 24 of the 31-Day #Pharmacist Month Challenge, with a special call to action to support the 40+ shows and incredible hosts creating content for the pharmacy profession through the Pharmacy Podcast Network. LINK: https://lnkd.in/efvZ6Smv Plus, Mike Johnston, CPhT-Adv, CEO of the NPTA - National Pharmacy Technician Association (NPTA), joins us to share insights on Meaningful Recognition and what pharmacy technicians truly want as we celebrate World Pharmacy Technician Day. LINK: https://lnkd.in/gz-Gcxvg 🎧 Empowering the profession, one story at a time. Thank you to Independent Pharmacy Cooperative (IPC) and Sykes & Company, P.A. for always supporting #TWIRx in the Works!!

📅 Release Date: October 17, 2025 🎧 Produced by: Pharmacy Podcast Network 🧠 Segment 1: Innovation Spotlight – OvaryIT & the PRISM Platform Guests: Mary Kucek, CEO & Founder, OvaryIT Devin Bustin, MD, Chief Medical Officer, OvaryIT The future of pharmacy practice management has arrived. Mary Kucek and Dr. Devin Bustin introduce PRISM, the first fully integrated EHR system built exclusively for community pharmacists. PRISM streamlines clinical workflows, ensures compliance, and empowers pharmacists to expand services—from point-of-care testing and chronic disease management to vaccinations and remote patient monitoring. This segment unpacks how PRISM helps protect your license, improve patient outcomes, and grow your business with technology designed by pharmacists, for pharmacists. 💡 Segment 2: Financial Literacy & Long-Term Care Planning with Michael Banner Guest: Michael Banner, Founder & Host, 62WhoKnew Podcast Michael Banner brings decades of expertise across the mortgage, financial, and LTC insurance industries to discuss how pharmacists and healthcare professionals can better educate aging populations about financial security and care planning. Learn why he built 62WhoKnew as the ultimate referral source for retirement preparation and hear insights on integrating long-term care insurance discussions into pharmacy-based clinical care models. 💰 Segment 3: The 8th Annual Pharmacy Profit Summit Guest: Lisa Faast, PharmD, CEO, DiversifyRx Get ready for the Pharmacy Profit Summit 2025—happening March 26–27 in Dallas, TX. Dr. Lisa Faast shares what’s new for the 8th annual event, including innovative strategies to boost profitability, reduce overhead, and future-proof independent pharmacies. Hear what attendees can expect from this year’s sessions, networking, and vendor showcases that make the Summit a can’t-miss event for forward-thinking pharmacy owners. 💬 Segment 4: TWIRx RxRated Roundtable – Trust, Transparency, and Controversy in Healthcare Hosts: Robbie Abasi, PharmD Sam Ilona, PharmD Xavier Hill, PharmD, BCPS, BCGP The RatedRx Podcast team joins TWIRx for an unfiltered discussion on trust in healthcare, media narratives, and the controversy shaping public perception of the profession. From patient misinformation to provider burnout, this roundtable doesn’t hold back—bringing authenticity and humor to the realities of modern pharmacy. 🔊 Episode Summary This week on This Week in Pharmacy, innovation meets impact. From next-generation EHR technology with PRISM to retirement readiness and LTC awareness with Michael Banner, plus a spotlight on profit-driven growth with DiversifyRx’s Lisa Faast—this episode covers the clinical, business, and human sides of pharmacy. We wrap it all up with RatedRx, where pharmacists talk real about the issues shaping trust in healthcare today.

This Week in Pharmacy – October 10, 2025 🎙️ Featured Guests: John Covello – Independent Pharmacy Cooperative (IPC) Garth Reynolds – Illinois Pharmacists Association (IPhA) Illinois pharmacy owners, this episode is for you. With the passage of HB 1697, a $70 million lifeline is now available to support independent pharmacies across the state—but the clock is ticking. The October 31st deadline is critical. Covello and Reynolds break down: The Critical Access Pharmacy Fund – how it strengthens local pharmacies. The DECO program – what it means for reimbursement. Patient Self-Management Programs (PSMP) – driving patient care and outcomes. The one-minute attestation that unlocks enhanced Medicaid dispensing fees. If you’re a pharmacy owner in Illinois, this could be the most important 30 minutes you’ll spend this month. 🎶 Special Feature: Mary Kutter This week, TWIRx also spotlights Mary Kutter, a rising country singer-songwriter from Kentucky. Known for her gritty, truthful storytelling, Kutter’s music explores themes of family, small-town struggles, and the opioid crisis. With viral songs like “Devil’s Money” and “The Devil Wore a Lab Coat”, plus songwriting credits for artists like Bailey Zimmerman, Kutter’s voice is shaping the soundtrack of rural America. Signed with Reservoir Media, she brings a raw perspective on how music can confront issues like addiction while honoring her Kentucky roots. 💡 Episode Highlights: The $70M opportunity Illinois pharmacies can’t afford to miss. How independent pharmacies can secure financial stability through HB 1697. Why Medicaid fee enhancements could change the game. Mary Kutter on blending country grit with the reality of the opioid epidemic. 📌 Don’t miss this episode of This Week in Pharmacy. It’s where policy, patient care, and culture intersect.

Celebrating the Launch of American Pharmacists Month 2025 “Caring for our Communities” This Week in Pharmacy (TWIRx) Friday, October 3, 2025 Episode Overview Today marks the kickoff of American Pharmacists Month 2025, a time to recognize the essential role pharmacists play across all healthcare settings. This special TWIRx episode spotlights leaders and innovators shaping pharmacy practice, technology, and patient care — and challenges the profession to embrace a 31-day journey of advocacy, community connection, and transformation. TWIRx NEWS Former Rep. Tiahrt: Pharmacy Benefit Manager bill could shut down CVS in Kansas | Opinion Read more at: https://www.kansas.com/opinion/guest-commentary/article312355904.html#storylink=cpy Neronha lawsuit against CVS Caremark can help save my Middletown pharmacy: Guest View https://www.newportri.com/story/opinion/columns/guest/2025/10/03/neronha-lawsuit-against-cvs-can-help-save-middletown-pharmacy-guest-view/86471928007/    FDA Approves Lurbinectedin Combination Regimen in Extensive-Stage SCLC https://www.pharmacytimes.com/view/fda-approves-lurbinectedin-combination-regimen-in-extensive-stage-sclc  Building an Opioid Stewardship Program in Cancer Care: Pharmacist Roles, Challenges, and Patient Safety https://www.pharmacytimes.com/view/building-an-opioid-stewardship-program-in-cancer-care-pharmacist-roles-challenges-and-patient-safety  Featured Guests Dr. Jesse McCullough, PharmD Founder, Keystone Pharmacy Insights Introducing the American Pharmacists Month 31-Day Challenge, a call to action for pharmacists to engage, educate, and elevate their communities. Bil Schmidtknecht Patient Protector Sharing insights on patient advocacy, protecting access to care, and the pharmacist’s role in navigating today’s healthcare complexities.   Dr. Devin Bustin, MD Chief Medical Officer, OvaryIt Dr. Lissette Logan, PharmD COO, OvaryIt Together, Dr. Bustin and Dr. Logan discuss innovative pharmacist-driven care models, treatment tracking, and platforms like PRISM designed to ensure pharmacists are recognized — and reimbursed — for their expertise.   Dr. Jill Kolesar, PharmD Dean, College of Pharmacy, The University of Iowa Highlighting the future of pharmacy education and how academia is preparing the next generation for expanded clinical and community roles. Dr. Jason Lang, PharmD Wellgistics Exploring the logistics and supply chain innovations that keep pharmacies agile in serving patient needs, especially as new therapies and technologies emerge. WELLGISTICS News: https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/wellgistics-health-nasdaq-wgrx-and-theracosbio-partner-to-expand-nati-1079815  SUBSCRIBE TO TWIRx HERE:  https://open.spotify.com/show/52NZjr9asE8fLrrbsMvBlQ  Celebrating the Launch of American Pharmacists Month 2025 | TWIRx 

On "This Week in Pharmacy" for September 26th, we're talking about Trust in Healthcare, World Pharmacists Day, and Cell & Gene Therapy. Today's co-host is Dr. Melissa Smith, PharmD CPH with Florida PGx Consulting LLC. https://www.floridapgxconsulting.com/  First, #TWIRx News - the FDA approves Inluriyo imlunestrant on 9/25/2025 which is to treat estrogen receptor-positive, human epidermal growth factor receptor 2-negative, estrogen receptor-1-mutated advanced or metastatic breast cancer with disease progression following at least one line of endocrine therapy. (https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2025)  Second, Nested-Knowledge - is going to revolutionize information access and leverage. This is a powerful tool with evidence synthesis tools for medical researchers. This will help accelerate, collaborate, automate and share the latest and personalized treatment plans. (https://nested-knowledge.com/) Next, announcing "Evidence based Podcasting", the new standard in audio learning for Providers and next level in podcast Continuing Medical Education (CME). (https://pharmacypodcast.com/2025/09/26/evidence-based-podcasting-and-the-future-of-medical-education/ ) Shout out to Nick Calla with Orsini, a leader in rare disease pharmacy solutions, has been chosen by Crinetics Pharmaceuticals, Inc., as a specialty pharmacy partner for PALSONIFY™ (paltusotine), a nonpeptide, selectively-targeted somatostatin receptor type 2 nonpeptide (SST2) agonist. (https://www.wvnews.com/news/around_the_web/partners/pr_newswire/subject/licensing_marketing_agreements/orsini-selected-as-specialty-pharmacy-partner-for-crinetics-palsonify-paltusotine/article_9b42bfe7-69a6-58be-98ff-5e2245145415.html) Today we have two guest Pharmacists to dig into the "Trust in Healthcare" theme of today's #TWIRx -- the godfather of Functional Pharmacy Robert Kress RPh., and Dr. Lauren Castle, PharmD, MS, AFMC - Founder & CEO of Functional Medicine Pharmacists Alliance. Who do you trust? What information is trustworthy and why?  Our special feature is updates on 'Cell & Gene Therapy' with McKesson's Head of Cell Gene Advanced Therapies, Joe DePinto at InspiroGene!  (https://inspirogene.com/)  Today's TWIRx is sponsored by 'Sykes & Company' the Pharmacy Accounting Jedi Masters and Independent Pharmacy Cooperative (IPC) and how they're revolutionzing digital health and new revenues with the iCare+ System!    Trust Matters, Cell and Gene, & World Pharmacists Day | TWIRx

Inmar Intelligence is a data-driven technology company that provides solutions for retail, healthcare, and supply chain industries. They specialize in optimizing promotions, managing digital couponing, and offering point-of-sale analytics for retailers. In healthcare, they focus on pharmaceutical returns, claims processing, and marketing. In supply chain, they help with inventory management and reverse logistics. Their data analytics platform uses AI to help businesses make smarter decisions, improve efficiency, and drive growth. TailorMed, led by CEO Srulik Dvorsky , is a healthcare technology company that focuses on helping patients manage the financial aspects of their medical care. The platform offers personalized financial assistance, helping patients find and access financial resources like insurance coverage, financial aid programs, and discounts to reduce out-of-pocket medical costs. Here are the key services TailorMed provides:  1. Financial Assistance for Patients: TailorMed helps patients navigate complex healthcare billing by identifying available financial aid, grants, discounts, and programs to reduce treatment costs. 2. Cost Transparency: The platform provides clear information on medical costs, helping patients understand their financial responsibilities and options for managing high healthcare expenses. 3. Technology-Driven Solution: TailorMed uses technology to automate the process of identifying financial resources and integrating these solutions into healthcare providers' systems, making it easier for providers to offer financial help to patients.  

On 'This Week in Pharmacy' we're talking about the "Fully Powered Event" with Dr. Christina Fontana, we jump into TWIRx News with Andy Crawford from Keysource, preparing for the NASP 2025 in Denver & welcome the Rated Rx Podcast to the PPN! TWIRx News includes: Massachusetts governor orders pharmacies to make COVID shots accessible - from CBS News  Hims & Hers stock jumps on Novo Nordisk GLP-1 partnership - from AOL Finance  The oldest pharmacy in Texas closes after 153 years - from DeWitt County Today  This episode is sponsored by Keysource and Sykes & Company, thank you for supporting the only weekly news podcast in pharmacy, this is TWIRx!! 

AI & Tech in Pharmacy & the Health Podcast Summit | TWIRx This week on TWIRx, we dive into how technology, artificial intelligence, and innovative media are shaping the future of pharmacy. From specialty pharmacy operations to digital health engagement and independent pharmacy innovation, our guests bring timely insights you won’t want to miss. TWIRx News FIP calls on authorities to ‘think humanity, think pharmacy https://ajp.com.au/news/fip-calls-on-authorities-to-think-humanity-think-pharmacy/  Iowa pharmacists are in demand as they try to fill healthcare provider gap https://www.radioiowa.com/2025/08/20/iowa-pharmacists-are-in-demand-as-they-try-to-fill-healthcare-provider-gap/ Nuvem Continues to Expand Leadership Team to Accelerate Pharmacy Service Model for Community Health Providers https://www.businesswire.com/news/home/20250820045021/en/Nuvem-Continues-to-Expand-Leadership-Team-to-Accelerate-Pharmacy-Service-Model-for-Community-Health-Providers    Featured Guest: Shaun Jensen, CEO of JB Consulting Topic: How Will Tech & AI Advance Specialty Pharmacy? The specialty pharmacy system is in flux—what platforms show real stability to build the future? Emerging use cases of AI in specialty pharmacy: clinical decision support, adherence optimization, and patient engagement. The role of AI in specialty trade relations and research, driving efficiency and better outcomes for providers, manufacturers, and patients. Daniel Couchman Kendall, CEO of Mission Based Media Topic: Announcing the Health Podcast Summit Introducing the Health Podcast Summit — the first global event dedicated exclusively to the intersection of health and podcasting. October 1–2, 2025 | Virtual Event | Free Registration at HealthPodcastSummit.com Learn evidence-based, human-centered frameworks for creating and growing health podcasts. Hear from industry leaders worldwide transforming patient engagement, professional education, and health outcomes through podcasting. On-demand replays available for registered attendees. Ketan Mehta, CEO of PrimeRx Topic: PrimeRx User Conference 2025 – XPLORE October 10–11, 2025 | The Westin Jersey City Newport Xplore by PrimeRx — an exclusive user conference designed for independent pharmacy professionals, healthcare innovators, and industry leaders. Explore pharmacy management strategies, technology advancements, and digital healthcare solutions that will shape the future of independent pharmacy. A chance to connect with peers, learn from experts, and prepare for the evolving pharmacy landscape. 🎧 Tune in for expert perspectives and actionable insights that show where pharmacy is headed.  👉 Don’t forget to subscribe to This Week in Pharmacy (TWIRx) on your favorite podcast platform.